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Abstract
Disuse osteoporosis is a condition in which reduced mechanical loading (e.g.
bed-rest, immobilization, or paralysis) results in unbalanced bone turnover. The
American black bear is a unique, naturally occurring model for the prevention of disuse
osteoporosis. Bears remain mostly inactive for up to half a year of hibernation annually,
yet they do not lose bone mechanical strength or structural properties throughout
hibernation. The long-term goal of this study is to determine the biological mechanism
through which bears maintain bone during hibernation. This mechanism could pinpoint
new signaling pathway targets for the development of drugs for osteoporosis prevention.
In this study, bone specific alkaline phosphatase (BSALP), a marker of osteoblast
activity, and tartrate resistant acid phosphatase (TRACP), a marker of osteoclast
number, were quantified in the serum of hibernating and active black bears. BSALP and
TRACP decreased during hibernation, suggesting a balanced reduction in bone
turnover. This decrease in BSALP and TRACP were correlated positively to serum
adiponectin and inversely to serum neuropeptide Y, suggesting a possible role of these
hormones in suppressing bone turnover during hibernation. Osteocalcin (OCN) and
undercarboxylated OCN increased dramatically in the serum of hibernating bears. These
increases were inversely correlated with adiponectin, glucose, and serotonin, suggesting
that OCN may have a unique role in energy homeostasis during hibernation. Finally,
MC3T3-E1 osteoblasts were cultured in the serum from active and hibernating bears,
and seasonal cell responses were quantified. Cells cultured in serum from hibernating
bears had a reduced caspase-3/7 response, and more living cells, after apoptotic threat.
The caspase-3/7 response was positively correlated to serum adiponectin and to gene
expression of OCN and Runx2, suggesting that reduced caspase-3/7 activity may be
related to the reduced differentiation potential of osteoblasts in hibernation serum, and
that adiponectin is a potential effector hormone. In summary, the activities of osteoblasts
and osteoclasts are reduced during hibernation in bears. This reduced turnover is due, in
part, to hormonal control. Further study of potential effectors adiponectin and
neuropeptide Y may provide insight into the biological mechanism through which bears
maintain bone throughout hibernation.
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Chapter One – Background and significance
1.1 Problem description/significance
Disuse osteoporosis is an increasingly common condition in which reduced
mechanical loading leads to degradation of bone tissue and increased bone fragility. The
risk of low-impact fracture, especially in the hip, spine, and wrist increases. This disease
state is a risk for the elderly (who have reduced activity due to exhaustion), victims of
stroke or spinal cord injury, and cosmonauts exposed to microgravity—as has been
recently reviewed [1-3]. According to the 2004 Surgeon General’s report on bone health
and osteoporosis, there are 1.5 million osteoporosis-related fractures annually, including
over 700,000 vertebral fractures. Such fractures severely diminish the patient’s quality of
life, as well as soaking up potential wages and increasing medical expenditures. An
estimated $18 billion (in 2002 dollars) are spent annually on direct medical care for
osteoporotic fractures. There are several anti-resorptive treatments available, although
these come with possible side effects such as osteonecrosis of the jaw for
bisphosphonates, and cardiovascular disease and cognitive impairment for hormone
therapy [4-9]. There is one FDA-approved anabolic drug for osteoporosis (Forteo, Eli
Lilly, Indianapolis, IN), but it is cost-restrictive and approved for only 18 months of use; it
is therefore limited in long-term efficacy [10-12]. The development of new anabolic
treatments for osteoporosis would benefit society by boosting quality of life and reducing
medical expenditures.
The goal of this study is to use a naturally occurring model for preventing disuse
osteoporosis to pinpoint new drug targets for osteoporosis therapy. Black bears (Ursus
americanus) provide such a model. In Northern climates, black bears undergo annual
periods of disuse (i.e. hibernation) and activity that are approximately equal in length
[13]. In humans and other animals, such a cycle would result in an annual deficit in bone
mass since bone must be reloaded for more than two times the length of unloading to
fully regain its mechanical properties [1, 14, 15]. However, black bears maintain cortical
bone mineral and structural integrity with age [16, 17]. Additionally, trabecular and
cortical bone are unchanged during hibernation in bears [18-21]. Thus, bears must
1

have evolved a mechanism to prevent bone loss during hibernation. This study will
explore the cellular mechanism behind bone maintenance in hibernating bears.

1.2 Basics of bone remodeling
Bone is a dynamic organ which responds to a complex array of endocrine,
neural, and mechanosensory stimulation by adapting its structure metabolically [22, 23].
The skeleton simultaneously serves two competing functions. Its first function is to
protect the internal organs and serve as a lever arm for locomotion. Bone must therefore
be strong and stiff, and it must respond to mechanical loading by remodeling its
structure. Its second function is as a reservoir for minerals such as calcium, phosphorus,
and magnesium. When serum levels decrease, bone must release these minerals by
breaking down (and therefore weakening) its structural integrity. Bone is therefore
subject to continuous remodeling such that most of the adult skeleton is recycled every
10 years. This remodeling is under the intricate control of three basic cell types.
Osteoblasts are the bone forming cells. They are derived from mesenchymal stem cells
located in the bone marrow. Following breakdown of bone, osteoblasts line the surface
of the resorption cavity and begin pumping out new organic matrix and proteins which
promote mineralization. As new bone is formed, some osteoblasts are trapped inside the
matrix. These cells terminally differentiate into osteocytes, which form long cytoplasmic
processes connecting these cells to other osteocytes, osteoblasts, and bone lining cells
[24]. These processes serve a mechanosensory function in bone [25]. The remaining
osteoblasts either undergo apoptosis or become quiescent bone lining cells, which form
a barrier between the bone surface and osteoclasts. Upon activation of resorption, bone
lining cells retreat from the bone surface, leaving an unprotected surface for osteoclast
attachment [26]. Osteoclasts serve as the bone macrophage. Upon signaling from
osteoblasts and osteocytes, hematopoietic stem cells terminally differentiate into
multinucleated osteoclasts, which tightly glom to naked bone surfaces, creating a
quarantined resorption cavity [27]. The osteoclast then releases acid and proteases
which disintegrate the mineral and cleave the organic matrix [28]. This process is
referred to as the activation and resorption phases of bone remodeling. It is followed by
the reversal and formation phases [29]. Bone resorption and formation are thus coupled,
ensuring that wherever bone is resorbed, new bone replaces it [30].
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1.3 Bone turnover is unbalanced during disuse
Like muscle, bone hails from a “use-it-or-lose-it” philosophy. Bone which is being
mechanically loaded by normal daily activities undergoes basal levels of remodeling—
mostly for mineral homeostasis and repair of normal fatigue microcracks. However, if the
bone is unloaded by immobilization or low gravity, the mechanosensory osteocytes
sense that the bone is no longer necessary and they signal the other cell types to begin
activation of resorption [22, 25]. An uncoupling of resorption to formation is the result.
Bone is broken down more rapidly than it is formed, leading to a net loss. This
uncoupling can be observed in serum resorption and formation markers in astronauts,
and in victims of stroke and spinal cord injury [31-33]. In contrast, serum resorption and
formation markers show that osteoclast and osteoblast activities remain balanced during
hibernation in black bears [34]. Furthermore, histological data demonstrates balanced
bone remodeling in black bears and in grizzly bears (Ursus arctos horribilis) [18, 20, 21,
35]. Thus, bears may conserve bone integrity during hibernation by maintaining
balanced bone resorption and formation. This balance in remodeling is likely driven
by the bear’s need to preserve homeostatic serum calcium. In most cases of disuse,
calcium mobilized by the breakdown of bone is excreted in the urine [36]. Bears do not
consume calcium, and do not excrete wastes during hibernation; however, serum
calcium levels remain constant throughout the year, suggesting that any calcium
released by bone resorption must be returned to mineralized bone by balanced
formation [35].

1.4 Osteoblast and osteocyte apoptosis results in bone loss
Current theories suggest that the decoupling of resorption to formation during
disuse may be due to increased osteoblast and osteocyte apoptosis [37]. According to
the Canalicular Fluid Flow hypothesis, bone can be thought of as a sponge filled with
extracellular fluid. The pores of the sponge are formed by the canals and lacunae
housing osteocytes and their processes. When a bone is loaded (i.e. taking a step), the
fluid is pushed out of the bone by a slight deformation. Upon unloading (picking the foot
back up again) the fluid returns to the pores. This cyclic loading and unloading applies a
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fluid shear on the osteocytes stimulating mechanosensory receptors [25]. The
convective fluid flow also provides nutrients to the cells. When an osteocyte no longer
senses cyclic loading, it undergoes apoptosis due to nutrient starvation and lack of
mechanical stimulation [22, 37, 38]. The apoptotic osteocytes initiate the osteoclastic
resorption of bone, probably through a pro-resorptive signaling cascade involving
TNF-α [39, 40]. In addition to stimulating osteoclast activation through osteocytic
apoptotic signaling, disuse may also induce osteoblast apoptosis, reducing the
population of bone forming cells. With fewer osteoblasts, the bone cannot be reformed
as efficiently, leading to an uncoupling of resorption and formation. Before thoroughly
discussing the roles of osteocyte and osteoblast apoptosis in disuse-induced bone loss,
it is necessary to review some key apoptosis regulatory pathways in this family of cells.

1.4.1 Review of apoptosis mechanisms in osteoblasts
Apoptosis is a form of genetically programmed cellular suicide in which damaged
or unneeded cells are removed from tissue, as reviewed recently [41]. The apoptotic
cascade is mediated by the activation of zymogens from the caspase family of cysteine
proteases. Caspase activity is closely regulated by the B-cell/Lymphoma-2 (Bcl-2) family
of proteins including pro-apoptotic BAX and BAD; as well as anti-apoptotic Bcl-XL and
Bcl-2. In the osteoblast, apoptosis can occur through two different pathways (Figure
1.1). The intrinsic pathway is initiated by damage to the DNA or an organelle. Following
such damage, the transcription factor p53 is activated—resulting in a halt in the G1
phase of the cell cycle, which allows time for the cell to repair itself. If repair is
unsuccessful, p53 up-regulates gene expression of BAX and down-regulates Bcl-2 [41].
BAX mediates the release of cytochrome C from the mitochondria by permeabilizing the
mitochondrial membrane and releasing cytochrome C monomers. These monomers
then bind apoptosis protease activating factor-1 (Apaf-1) and caspase-9 monomers
forming a gigantic (~1MDa) oligomeric complex called an apoptosome, or “the wheel of
death” [42]. This complex activates effector caspases by zymogen cleavage. The
extrinsic pathway involves stimulation of a death receptor (or perhaps, in the case of
disuse, lack of stimulation of a mechanosensory receptor). Stimulation of the death
receptor results in activation of caspase-8 which then activates effector caspases-3 and
-7. Separately, caspase-8 also interacts with the intrinsic pathway by indirectly activating
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pro-apoptosis regulator BAX. An important trait of the Bcl-2 family is its ability to form
heterodimers. Due to dimerization, the ratio of anti-apoptotic monomers to pro-apoptotic
monomers can tip the balance from a healthy to an apoptotic cell [43, 44]. In this way,
there is additional regulation of the intrinsic pathway by anti-apoptotic Bcl-2 and Bcl-XL,
which can bind to and neutralize BAX. In turn, pro-apoptotic BAD can bind to and
neutralize Bcl-XL and Bcl-2.
Extrinsic Path
Serum Starvation;
Absence of
mechanical stimulation

Intrinsic Path
Damage to DNA or organelle

p53

Caspase 8

BAD

BAX

Caspase 3 & 7

Bcl-2

Caspase 9

Cytochrome C
& Wheel of
Death

+

Apoptosis
Figure 1.1—Simplified schematic of the apoptosis pathways
Induction of osteocyte apoptosis due to disuse could be initiated through the extrinsic pathway
(reduced stimulation of mechanosensors), or the intrinsic pathway (organelle damage due to
reduced blood flow and free-radical formation). There is also cross-talk between the two
pathways. The arrows represent stimulation of a pathway, the bar-dash represent inhibition of
a pathway. Information compiled from: [1-3].

Apoptosis can be quantified by several means. Gene and protein expression of
various early-stage apoptosis regulators such as Bcl-2 family members are commonly
measured, though a change in these regulators does not necessarily translate to a
comparable change in apoptosis rates. The protease activity of effector caspases-3, -6
and -7 are often quantified, as activation of these late-stage apoptosis regulators is a
better indication of the cell’s eventual demise. Another common technique is to quantify
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DNA damage due to nuclease cleavage. Nick-end labeling techniques such as TUNEL
will label the naked 3’-OH in breaks created by nuclease activity, though this technique
can incorrectly label cells with DNA damage destined for repair [45, 46]. It is also
possible to use gel electrophoresis or ELISA techniques to quantify a later state of DNA
digestion, “DNA laddering.” By this stage, nucleases have broken down DNA
systematically at linker sites between histones, creating monomers, dimers, and trimers
of DNA/histone chunks. The cell’s DNA is irrevocably digested and this is a suitable endpoint indicating definite cell apoptosis. Also, in cell culture, percent cell death can be
quantified by means of calcein and ethidium bromide (EtBr) uptake (or a similar method),
although this technique counts necrotic cells as well as apoptotic cells under the same
category—dead.

1.4.2 Apoptosis precedes disuse-induced bone loss
As stated earlier, evidence suggests that apoptotic osteocytes promote the
differentiation of osteoclasts, leading to targeted resorption in the areas surrounding the
apoptotic osteocytes. A study in rabbit tibiae demonstrates a positive correlation
between osteocyte apoptosis and serum resorption markers, but no correlation with
formation markers, suggesting that increased osteocyte apoptosis could result in
uncoupled remodeling and net bone resorption [47].
The mouse/rat hind-limb unloading model demonstrates that disuse-induced
bone loss is preceded by osteocyte apoptosis, and that osteoblast apoptosis is also
present [48-51]. In hind-limb unloaded mice, this increase in apoptosis could be due to
higher gene expression of p53 in femoral bone marrow [52]. Hind-limb unloaded wildtype mice lose 45% of their tibial bone volume and have significantly reduced bone
formation rate (BFR) and increased osteoclast number compared to ground controls;
whereas genetically similar p53 knockout mice show no significant changes in these
variables [53]. In hind-limb unloaded rats, an observed increase in osteoblast and
osteocyte apoptosis is likely due to a decrease in protein levels of Bcl-2 with unchanged
Bax levels in the femur metaphysis; furthermore, apoptotic cell numbers in these rats are
not correlated to endogenous glucocorticoids, suggesting an alternative mechanism for
apoptotic induction may be responsible [54]. Attenuation of apoptosis by intermittent,
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low-dose administration of parathyroid hormone (PTH) lengthens the lifetime of mature
osteoblasts, thus increasing BFR and bone mineral density (BMD) of the spine and hindlimbs of mice [49, 55]. Low-dose, intermittent administration of PTH abates bone loss in
hind-limb suspended mice [56]. Additionally, attenuation of apoptosis by administration
of sex steroids or melatonin abates bone loss in ovariectomized rats [57, 58], indicating
osteoblast and osteocyte apoptosis may play a key role in bone loss due to estrogen
deficiency as well.
Together, these results suggest that disuse-induced osteocyte and osteoblast
apoptosis leads to an uncoupling of bone formation and resorption leading to net bone
loss, and that this mechanism can be controlled by hormones. Administration of antiapoptotic hormones can counteract the pro-apoptotic signaling from disuse, thus
enabling balanced bone formation and resorption. Similarly, if apoptosis of bone cells
were inhibited during hibernation in bears, formation and resorption would remain
coupled, resulting in balanced bone turnover, as observed in grizzly bears [20]. It is
possible that bears maintain balanced bone turnover during hibernation by upregulating anti-apoptotic serum factors (or by down-regulating pro-apoptotic
factors), thus decreasing osteoblast and osteocyte apoptosis. This study quantified
serum concentrations of several bone-active hormones and explored the anti-apoptotic
potential of seasonal bear serum on an osteoblast cell line.
In contrast to hind-limb unloading models, simulated microgravity does not
induce osteoblast apoptosis, although bone mass is lost during space flight due to an
increase in bone resorption with a decrease in bone formation [31, 59]. Human primary
osteoblasts, mouse primary osteoblasts, and the immortalized pre-osteoblast cell line
MC3T3-E1 do not undergo apoptosis when cultured in simulated microgravity compared
to static controls [60-62]. Thus, microgravity appears to be a unique form of disuse, and
care must be taken not to generalize between the different forms of disuse osteoporosis.

1.5 Disuse in humans
Osteopenia due to reduced mechanical loading occurs in a variety of clinical
situations and can therefore be a threat to anybody, regardless of age and current
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activity level. As much as 6-32 months following anterior cruciate ligament surgery, the
BMD of the involved hip can be 3.4-6.6% lower than in the unaffected hip [63]. Patients
confined to bed-rest can lose 4% of hip BMD after 60 days of bed-rest [64]. When
confined for up to 90 days in bed, patients lose approximately 1% BMD in the hip per
month of confinement [65]. Military personnel can also be at risk. Turkish armed forces
who suffered transtibial amputations from land-mine injuries have reduced BMD in the
remaining amputated limb compared to the non-amputated limb [66]. This reduction in
BMD not only increases the chance of fracture, but also may be one cause of residual
limb pain. After 30 days of submersion in submarines, the bone strength (measured by
speed of sound) of submariners’ right tibias decreased significantly, accompanied by a
decrease in bone formation and resorption serum markers; bone strength continued to
decrease through the first month of return to land and was fully restored after 6 months
[67]. After 4-14 months of spaceflight, cosmonauts can lose 0.34-1.56% BMD per month
in various loaded bones such as the hip, leg, and spine [1]. Finally, loss of bone due to
disuse can also occur after a stroke or a spinal cord injury. In patients suffering from a
paretic arm more than 1 year after a stroke, the BMD, bone cortical mineral density,
cortical thickness, and bone strength of the distal and midshaft radius are significantly
reduced in the paretic arms compared to the mobile arms [68, 69]. Within 71 weeks
following spinal cord injury, patients lose 15% of BMD in the pelvis and lower limbs [70].
The fracture risk of patients with spinal cord injury increases with the degree of motor
impairment [71, 72].

1.6 Disuse in non-hibernating animals
Reduced bone strength and mineralization under conditions of disuse seems
universal among the animal kingdom, with the exception of some hibernating animals. In
birds, disuse osteopenia has been reported in turkey, chicken, pigeon, and cockatiel
[73-78]. After four weeks of unloading, the ulnae of turkeys lose 12% of cortical area,
with decreased cortical thickness and increased porosity compared to normally loaded
controls [73]. Two weeks of unloading lead to a 50% reduction in bone mineral content
and a 40% reduction in structural strength of chicken tibiae [76]. The calcanei of sheep
immobilized from the tibia to the metatarsus for 12 weeks experience an 18-29%
decrease in trabecular bone volume compared to the non-immobilized limb [79, 80]. A
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decrease in bone trabecular thickness in this model is due to an unbalanced increase in
osteoclast and osteoblast activity, leading to net bone resorption [81]. The metacarpus III
of horses lose 10% of BMD after 140 days of forelimb immobilization; this loss is
accompanied by an increase in the serum resorption marker crosslinked carboxyterminal
telopeptide of type I collagen (CTX) with no change in the bone formation marker bone
specific alkaline phosphatase (BSALP), suggesting that the loss in BMD is due to an
increase in bone resorption with no change in the formation rate [82]. Cats and dogs are
also vulnerable to disuse osteoporosis [14, 83-85]. The immobilized humeri of dogs have
significantly reduced BMD as well as a 71-98% decrease in cortical strength and a
28-74% decrease in trabecular strength than the contra-lateral humeri after 16 weeks of
left forelimb immobilization [14]. There is also a wealth of studies which quantify bone
loss in more common laboratory animals such as non-human primates [86-89], rats
[90-98], and mice [48, 99-102]. It is very well established that most animals lose bone
when subjected to periods of reduced mobility, so it is exciting to study an animal like the
hibernating bear, which can undergo months of disuse without losing bone.

1.7 Hibernation as a model of disuse
Hibernation is a state of greatly reduced physical activity and bouts of reduced
metabolism which conserves energy through seasonal periods of reduced food
availability. The physical activity of bears rapidly declines in the weeks immediately
preceding hibernation, and bears remain mostly inactive throughout their denning period
[13]; thus, hibernation should be an adequate model of disuse (for review see [103]).
However, bears maintain BMD and mechanical strength despite these extended periods
of disuse. Mechanical analysis of bones taken before and after hibernation [21],
seasonal serum markers of bone metabolism [34, 35], and seasonal histological indices
of cortical and trabecular remodeling [18, 20] together suggest that the rate of bone
formation equals the rate of resorption during hibernation in the bear. Thus, there is no
net change in size (e.g. length, thickness), BMD, nor mechanical strength of bone. In
contrast, most existing studies in smaller hibernators suggest that at least some of these
animals lose bone during winter sleep [104-109]. However, these early studies in small
hibernators are qualitative, and recent quantitative data suggest bone loss may be at
least partially suppressed in hibernating golden-mantled and thirteen-lined ground
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squirrels [103, 110]. An understanding of the physiology of hibernation is essential
before determining how bears (if not smaller animals) are able to maintain bone
throughout hibernation.

1.7.1 Physiology of hibernation
Because hibernation in bears is a state of energy conservation during a period of
fasting combined with reduced ambient temperatures, the body temperature, heart rate,
and metabolic rate all decline during hibernation (for review see: [13, 111]). During
hibernation, the bear’s body temperature decreases from 37-39oC to 34oC. The heart
rate plummets from its summer value of 40 beats per minute to as low as 8 beats per
minute during denning. Bears do not eat throughout hibernation; therefore they rely on
fat stores to support their energy needs during this time. Leading up to hibernation,
bears forage to dramatically increase their fat mass, which is catabolized during winter
sleep. Bears that would normally consume 8000 kilocalories during the summer will
increase to 15,000-20,000 kilocalories in preparation for winter [111]. They will expend
approximately 4,000 kilocalories per day during hibernation (calculated based on fat
utilization rates) [111]. A bear can lose between 15-25% total body weight during
denning [112]. This lost weight is almost entirely fat, as lean body mass and hydration of
the non-lactating bear remain unchanged by hibernation [112], despite the fact that
bears do not drink during this time. Hibernating bears are able to remain hydrated by the
water produced through the combustion of fat [13]. Bears have reduced renal function
during hibernation and their bladders maintain a constant urine volume despite going for
up to half a year without urinating [113, 114]. Most importantly, bears remain eucalcemic
throughout hibernation [35]. Since they do not excrete wastes nor consume food and
water while hibernating, the calcium in circulation must remain in equilibrium with
calcium in the bone; thus, any calcium that is mobilized by bone resorption must be
reincorporated into newly formed bone.
Small hibernators attain a much deeper state of hibernation than bears.
Reductions in metabolic rate [115-117], heart rate [118, 119], and body temperature
[117, 120] are more profound in small hibernators compared to bears. Unlike bears,
small hibernators do not remain immobile throughout hibernation. Every 3-25 days they
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experience periodic arousals in which they experience bursts of high metabolism that
raise their body temperatures back to near-normal levels [115, 121, 122]. Because of
these intermittent arousals, small hibernators reload their bones periodically throughout
winter; though this reloading probably remains minimal since these animals are confined
to small burrows during hibernation. Small hibernators also periodically excrete wastes
such as urine [122-124], which could result in net excretion of calcium throughout the
winter. Thus, calcium mobilized by resorption of bone during hibernation in small animals
may not be available for incorporation into newly forming bone as it would be in the bear.
These differences in metabolism and calcium excretion could explain why small animals
may lose bone during hibernation, whereas bears do not.

1.7.2 Bone response to hibernation—small hibernators
Early studies in the bone of small hibernators—including the little brown bat
(Myotis lucifugus), golden hamster (Mesocricetus auratus), and 13-lined ground squirrel
(Ictidomys tridecemlineatus)—suggest that these animals undergo disuse-induced bone
loss during hibernation [104-109, 125, 126]. Between fall and spring, bone porosity
increases due to enlarged osteocyte lacunae [104, 105, 108, 109, 126]. Hibernating bats
and hamsters reduce cortical bone thickness [104, 105, 108, 126]. Bone mineral content
decreases in the hibernating bat [125]. Although these studies all suggest that small
hibernators lose bone during hibernation, most of them are based on qualitative
observations (for review see: [103]). Some quantitative data have been collected more
recently in the golden-mantled ground squirrel (Callospermophilus lateralis) [110]. This
study found that femoral and tibial bone strength is not affected by 8 months of
hibernation. The Donahue lab has collected some preliminary quantitative data on the
femurs of 13-lined ground squirrels, finding that during the hibernation season bone is
lost on the microstructural scale due to increased lacunar size; however, despite these
microstructural changes, the bone geometrical properties and mineral content were not
different before, during, and after hibernation [103]. Therefore, more comprehensive
studies need to be completed before interpreting the effects of hibernation on bone of
small animals.
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1.7.3 Bone response to hibernation—bears: histological and mechanical data
Histological and mechanical data demonstrate that bears do not lose bone during
hibernation. In other animals, when bone is lost due to mechanical unloading, the bones
must be reloaded for more than twice the time of unloading before the lost bone is
regained [1, 14, 15, 127]; however, bears hibernate for periods as long as half the year,
and only reload for the remaining half-year. These cycles should result in an annual
deficit of bone, but the cortical bone bending strength and mineral content of black bears
increases with age, while porosity remains unchanged [16, 17]. This increase in mineral
and structural integrity occurs at approximately the same rate as in humans of similar
age ranges (i.e. age normalized to life span) [128]. These data demonstrate that bears
do not experience an annual deficit of bone. To determine whether bears maintain bone
throughout hibernation, or if they lose bone only to regain it by increased formation in the
weeks immediately following hibernation, studies were performed with grizzly bear
femurs harvested during summer-active and hibernating seasons. These studies
demonstrated that bone geometry and strength were not different in the hibernating
bear, while mineral content increased and porosity decreased during hibernation [20]. In
contrast, porosity increases and mineralization decreases in the bones of most animals
undergoing disuse [129, 130]. Bone loss in trabecular bone is also important to disuse
studies, since the increased surface area of this sponge-like bone renders it highly
susceptible to resorption during disuse [131, 132]. Early studies comparing ilium
biopsies of black bears in fall and spring have suggested that bears do not lose
trabecular bone during hibernation [35]. Similarly, a study in the radius of hunter-killed
black bears collected in the fall and spring demonstrate no seasonal differences in
trabecular bone mineral content, trabecular thickness, or trabecular bone volume fraction
[19]. Studies performed in the distal femoral metaphysis, distal femoral epiphysis, and
ilium of hibernating and active grizzly bears confirm that hibernation has no effect on
trabecular bone structural properties or mineral density [18].
In summary, structural and mechanical properties of bear bones are not affected
by hibernation either in the long term (with age) or from season to season within one
year. Other animals would suffer severe loss of bone after 6 months of not moving, and
would not be able to gain it back during the remaining 6 months of activity; therefore,
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bears must have evolved a mechanism to combat disuse-induced bone loss during
hibernation. This mechanism must conserve the balance between bone resorption and
formation such that there is no net change in bone accrual. Resorption and formation
may remain in equilibrium in three ways: 1) neither the bone resorption nor the formation
rate changes; 2) resorption and formation rates increase with the same acceleration;
3) resorption and formation rates decrease with the same deceleration. Analyses of
serum markers of bone turnover and histomorphometric indices of cellular activities are
widely used methods to ascertain whether resorption and formation rates have changed.

1.7.4 Bone response to hibernation—bears: serum formation markers and
histomorphometry
Serum markers for bone formation (osteocalcin (OCN), carboxy-terminal of
propeptide of type I procollagen (PICP)) and resorption (carboxy-terminal cross-linked
telopeptide of type I procollagen (ICTP)) exhibit a balanced increase in the hibernating
compared to the active bear [34, 133, 134]. Furthermore, concentrations of calcium in
the blood remain seasonally constant, although bears do not consume or excrete
calcium during hibernation [35, 135]. These data suggest that bone resorption increases
during hibernation, but that mobilized calcium is returned to the bone by increased
osteoblast activity. In contrast, histomorphometric indices of trabecular and cortical bone
suggest that although bone resorption and formation remain balanced during
hibernation, the osteoclast and osteoblast activities are both dramatically reduced during
winter sleep [18, 20]. These paradoxical findings could be explained in a few ways. One
explanation is that although bone turnover decreases in the locations of biopsies, the net
turnover of the entire skeleton increases during hibernation. However, the biopsies were
collected from several locations, and all of them suggest a sharp reduction in turnover
[18, 20]. Furthermore, an increase in bone turnover with no net change in bone quantity
or quality would be an energetically costly effort for no apparent benefit. During this
extended period of fasting, a reduction in bone metabolism is more advantageous.

13

1.7.5 Hypothesis 1: BSALP and TRACP reduction during hibernation
Another explanation of the conflicting histological and serum marker data is that
the serum markers quantified could have accumulated in the blood during hibernation
due to reduced net urine production. During hibernation, the rate of urine filtration is
reduced by approximately 30% of summer values to a urine production rate of 100mL
per day [113], and water and urea are reabsorbed into the bloodstream through the
bladder wall at the same rate as urine is produced [114] (For review see: [13, 111, 124,
136]). The hibernating bear therefore experiences some of the physiological effects of
reduced renal function such as an accumulation of serum creatinine [112, 113, 137-139],
and may be compared to human hemodialysis patients. Neither ICTP [140-142] nor
OCN [143-146] is considered a good serum marker of bone turnover in patients with
reduced renal function, because these factors are normally filtered out by the kidney (for
review see: [147]). In humans, a 30% decrease in glomerular filtration rate results in an
approximate 65% increase in serum OCN [148]. The hibernating bear, like a human
patient with reduced renal function, may accumulate circulating OCN and ICTP;
therefore, these markers may reflect glomerular filtration rates rather than bone turnover.
To

determine

whether

serum

markers

of

bone

turnover

conflict

with

histomorphometric data, it is necessary to quantify serum markers that do not
accumulate due to reduced renal function. Two such serum factors, the formation
marker BSALP [143-145] and tartrate-resistant acid phosphatase (TRACP) [148, 149],
an indicator of osteoclast number, are not influenced by renal function.
(1) The first Aim of this study was to quantify the markers BSALP and
TRACP in the serum of black bears every 10 days from October through
the beginning of May, thus encompassing prehibernation, hibernation,
and post-hibernation periods.

The hypothesis was that BSALP and

TRACP activities would coincide with previous histomorphometric data
to suggest that bone formation and resorption remain balanced, though
decreased, during hibernation.
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1.7.6 Hypothesis 2: OCN interacts with energy metabolism
A third explanation of the discrepancy between histomorphometric data and bone
turnover markers is that some of the factors quantified may be up-regulated in the serum
during hibernation as hormonal signals to other tissues. For instance, circulating OCN
can function as a hormone to regulate energy metabolism (for review see: [150, 151]). In
mice, the undercarboxylated form of OCN (ucOCN) increases adiposity and the
secretion of adiponectin from adipocytes, it promotes the proliferation of pancreatic
β-cells and their secretion of insulin, and it enhances insulin sensitivity [152, 153]. Thus,
increased OCN, especially ucOCN, could have an array of complex effects on the
physiology of energy metabolism during hibernation. ucOCN could increase adiponectin
secretion during hibernation [152, 153], thus promoting more efficient glucose uptake
and fatty acid oxidation [154, 155]. In addition, an increase in adiponectin during
hibernation could potentially offset disuse-induced osteoblast loss by increasing
osteoblast differentiation and proliferation [156-158]. Thus, it is possible that bears
increase circulating OCN levels during hibernation as a mechanism to control
energy metabolism during this period of low energy expenditure.
(2) The second Aim of this study was to quantify total and ucOCN, glucose,
insulin, and adiponectin in the serum of black bears every 10 days from
October through the beginning of May. The hypothesis was that OCN,
ucOCN, insulin, and adiponectin would all increase and glucose would
decrease in the serum of hibernating bears (compared to that of active
bears). ucOCN levels were expected to have a positive relationship to
insulin and adiponectin, and a negative relationship to glucose levels.

1.7.7 Hypothesis 3: Reduced apoptotic serum factors during hibernation
In addition to asking why bone turnover markers do not match histomorphometric
indices, another question was asked: how do hibernating bears maintain bone structure
and strength during this extended period of disuse? It has been suggested that bear
bones (and muscles) are mechanically loaded during hibernation by shivering, thus
preventing atrophy [19, 159]. During hibernation periods greater than one hour, captive
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grizzly bears exhibit low levels of shuddering (<0.2 seconds of muscle activation every
3-10 seconds) [159]. However, high-frequency, low-magnitude loading is not anabolic on
cortical bone [160] and bears in the Donahue, et. al. studies maintain cortical bone
properties [20, 21, 161]. Furthermore, grizzly bears only start shivering after their body
temperatures have dropped >5oC (Brian Barnes, personal communication), but the
bears used by Donahue, et. al. rarely drop past this threshold. Therefore it is probable
that another mechanism for maintaining balanced bone formation and resorption is
responsible.
As stated earlier, it is possible that bears maintain balanced bone resorption and
formation during hibernation by inhibiting osteoblast and osteocyte apoptosis. Osteocyte
apoptosis precedes bone loss in unloaded mice, and attenuating osteocyte and
osteoblast apoptosis with injections of PTH will inhibit this bone loss [48-51, 56]. It is
possible that osteoblast and/or osteocyte apoptosis is required for disuse-induced bone
loss, although currently no studies have explored this idea. However, a study with a
pan-caspase inhibitor in ovariectomized mice demonstrates that caspase activation is
required for bone loss in this model of osteoporosis [162]. Many hormones are known to
regulate osteoblast and osteocyte apoptosis, the most notable of which are PTH [49, 55]
and steroid hormones like estrogen [57]. If concentrations of anti-apoptotic
hormones increase during hibernation in bears, bone loss may be prevented
during this period of extended disuse.
Apoptosis-inducing threats are prevalent in hibernating animals—these include
prolonged drops in temperature, substantial decreases in oxygen transport to tissues,
metabolic acidosis, anorexia, and disuse—yet hibernating animals do not seem to suffer
from large-scale apoptotic response (for review see: [163]). Despite this qualitative
observation that hibernating animals seem resistant to apoptosis, few studies have
specifically quantified apoptosis in tissues from hibernating animals. Although the
expression of the anti-apoptotic protein Akt increases in the gut of hibernating ground
squirrels, the amount of activated (i.e. phosphorylated) Akt during winter remains
unaffected compared to summer values [45]. However, this study found a decrease in
phosphorylated Akt in the gut mucosa of torpid ground squirrels compared to inter-bout
arousal squirrels [45]. Reduced Akt phosphorylation has also been observed in the
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brain, heart, and femoral muscle of hibernating ground squirrels compared to winter
warm-adapted (active) squirrels [164]. Similarly, levels of phosphorylated Akt in the
brain, kidney, liver, and white adipose tissue of torpid bats was lower than levels in bats
aroused from hibernation [165]. This hypophosphorylation of Akt may not increase
apoptosis in the hibernating animal. It is possible that reduced levels of phosphorylated
Akt may act through FoxO transcription factors to induce a state of hypometabolism
which protects cells from glucose and oxygen deprivation [164, 166, 167]. Thus, in the
low-energy environment of hibernation, hypophosphorylation of Akt may prevent cell
death, rather than promote it.
A few studies have explored the effects of hibernation on TUNEL staining. The
seminiferous epithelium of cold adapted (hibernating) Syrian hamsters had more TUNEL
positive cells than warm adapted (active) hamsters [168]. TUNEL positive cell numbers
increased in the brains of hibernating frogs (Rana esculenta) compared to summeractive frogs [169]. The number of TUNEL positive enterocytes in the midvillus region of
summer squirrels was higher than the number in winter (hibernation) squirrels [45]. This
trend in TUNEL positive cells increased with time as winter progressed, such that latehibernation squirrels had the highest number of TUNEL positive cells [45]. In contrast,
this study also demonstrated that caspase-3 activation in the gut of hibernating ground
squirrels decreased compared to active squirrels, and no DNA laddering was present in
hibernation gut tissue [45]. These data suggest that TUNEL stains in hibernating tissues
may be inaccurately interpreted as an increase in apoptosis. It is possible that the
increase in TUNEL positive cells during hibernation may be due to an accumulation of
damaged DNA during this season [45]. Therefore, it is unclear from these studies
whether apoptosis is generally inhibited during hibernation, though the study in gut
tissue would suggest a suppression of apoptotic signaling overall [45], and qualitative
assessments of tissue survival in hibernation suggest that apoptosis-mediated tissue
damage is minimized at this time [163]. It is possible that an alleviation of osteoblast
and osteocyte apoptosis during hibernation (possibly through circulation of antiapoptotic hormones) combats bone loss.
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(3) The third Aim of this study was to quantify concentrations of antiapoptotic hormones (e.g. PTH, melatonin) in the serum of black bears
every 10 days from October through the beginning of May. Osteoblasts
were cultured in media supplemented with seasonal bear serum to
determine the cellular response (e.g. caspase-3 activation, cell death).
The hypothesis was that serum levels of an anti-apoptotic hormone
such

as

PTH

would

increase

during

hibernation,

and

that

concentrations of this hormone would be negatively correlated with the
caspase-3 activation and cell death.
The reasoning behind this Aim was that if apoptosis in bone is inhibited during
hibernation through a serum-borne hormone, then cells cultured in hibernating bear
serum may be less susceptible to apoptosis than cells cultured in active serum.

1.8 Hypotheses and Aims
Hypothesis 1: Serum concentrations of BSALP and TRACP are lower in samples taken
from hibernating bears than those from active bears.
Aim 1: Quantify the markers BSALP and TRACP in the serum of black bears every 10
days from October through the beginning of May. Determine longitudinal trends
for each bear.
Hypothesis 2: Serum concentrations of OCN, ucOCN, insulin, and adiponectin increase,
and glucose levels decrease, in the serum of hibernating bears (compared to that
of active bears). ucOCN levels have a positive relationship to insulin and
adiponectin, and a negative relationship to glucose levels.
Aim 2: Quantify OCN, ucOCN, glucose, insulin, and adiponectin in the serum of black
bears every 10 days from October through the beginning of May. Determine
longitudinal trends for each bear. Use regression analysis to find any
relationships between the concentrations of these serum factors.
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Hypothesis 3a: Serum concentrations of anti-apoptotic hormones (e.g. PTH, melatonin)
are higher in samples taken from hibernating bears than those from active bears.
Hypothesis 3b: Serum from hibernating bears provides an anti-apoptotic environment for
osteoblasts in culture (compared to serum from active bears). The response of
osteoblasts to apoptotic stimulus is suppressed in cells cultured in hibernating
bear serum (compared to those in active bear serum).
Aim 3a: Quantify concentrations of anti-apoptotic hormones (e.g. PTH, melatonin) in the
serum of black bears every 10 days from October through the beginning of May.
Determine longitudinal trends for each bear.
Aim 3b: Culture osteoblast-like cell line MC3T3-E1 in media supplemented with bear
serum and determine the cellular apoptotic response (e.g. caspase-3 activation,
cell death). Use regression analysis to find any relationships between apoptotic
response and anti-apoptotic hormone concentrations.
These Aims will be discussed in a series of chapters written in the form of journal
articles for publication. Chapter 2 will address Aims 1 and 2 as outlined above, and will
discuss how the interplay between energy homeostasis hormones and bone metabolism
could benefit a hibernating bear by reducing energy expenditure. Chapter 3 will further
address Aim 1, and will propose several hormones which may reduce bone metabolism
and prevent disuse-induced bone loss during hibernation in bears. Chapters 4 and 5 will
address Aims 3a and 3b, respectively. Chapter 5 will demonstrate that osteoblasts
cultured in serum from hibernating bears are less responsive to apoptotic stimulus than
cells cultured in serum from active bears. Additionally, it will outline a series of
experiments to characterize the serum factor responsible for this seasonal apoptotic
response. Finally, Chapter 6 will demonstrate that seasonal bear serum does not
dramatically affect the gene expression of cultured osteoblasts. Although the long-term
goal of identifying the mechanism through which hibernating bears maintain bone
despite extended periods of disuse is still in the future, this study provides insights into
the hormonal regulation of bone metabolism during hibernation. The findings from this
study can be used to develop future experiments in quest of the long-term goal.
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Chapter Two — Serum osteocalcin is inversely associated
with adiponectin, glucose, and serotonin in black bears
2.1 Introduction
Despite

bears’

inactive

states

throughout

the

months

of

hibernation,

histomorphometric indices of trabecular and cortical bone suggest that although
osteoclast and osteoblast activities dramatically decrease [18, 20], bone resorption
remains balanced with bone formation during hibernation. In contrast, the bone
resorption marker ICTP and formation marker OCN both display steep increases in the
serum of hibernating black bears [34, 133, 134]. The purpose of hibernation is to
conserve energy during the long anorectic periods of winter. Retaining balanced, though
reduced, bone turnover (as is suggested by the histomorphometric data) is energetically
favorable to increased turnover; therefore it is possible that the turnover markers
accumulate in the serum during hibernation for other reasons.
One possible reason for the increase in serum turnover markers is reduced renal
function. During hibernation, the bear’s renal function is decreased by 30% from summer
values [113]. The hibernating bear therefore experiences some of the physiological
effects of reduced renal function such as an accumulation of serum creatinine [112, 113,
137], and may be compared to human hemodialysis patients. ICTP is mobilized into the
circulation upon bone resorption, and is therefore considered a marker of osteoclast
activity [170, 171]; however, it is not considered an effective indication of bone resorption
rates in patients with reduced renal function as it exits the blood-stream through urine
[140-142]. OCN is secreted by osteoblasts during the formation of bone and is
commonly used as a marker of bone formation. It also accumulates in the serum of
patients with reduced renal function and is not considered an ideal marker of bone
formation rates in hemodialysis patients [143-146]. Quantifying serum markers that do
not accumulate with decreased renal function would therefore help clarify any
discrepancy between histomorphometric indices and serum markers of bone turnover.
Two such serum factors are BSALP [143-145], a marker of osteoblast activity, and
TRACP [148, 149], a marker of osteoclast number. Neither is influenced by renal
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function. Therefore, the first goal of this study was to quantify BSALP and TRACP in the
serum of hibernating and active American black bears. The hypothesis was that serum
BSALP and TRACP activities would fall during the months of hibernation, coinciding with
the reduced osteoblast and osteoclast activities observed in histological studies [18, 20].
Another possible explanation for the apparent discrepancy between serum
markers and histomorphometric indices of bone turnover during hibernation is that the
accumulating serum factors may be acting as hormones to impact other tissues during
hibernation. For instance, OCN can function as a hormone to regulate energy
metabolism (for review see [150, 151]). In order to function properly, OCN is posttranslationally γ-carboxylated on multiple glutamine residues, in a vitamin K-dependent
reaction. In mice, ucOCN increases adiposity and the secretion of adiponectin from
adipocytes, it promotes the proliferation of pancreatic β-cells and their secretion of
insulin, and it enhances insulin sensitivity [152, 153]. The second goal of this study was
to quantify the serum levels of OCN and to determine whether increased OCN levels
during hibernation were associated with increases serum insulin and adiponectin. Such
a relationship would suggest that OCN may act as a hormone to help regulate energy
metabolism during hibernation.

2.2 Methods and materials
2.2.1 Bear handling and sample collection
The Virginia Polytechnic Institute and State University Animal Care Committee
approved all bear handling protocols (#98-069-F&WS). A total of 16 female black bears
were captured and held in pens in the Virginia Tech Center for Bear Research from fall
through spring, between the years 2003 and 2009. Each bear was held for a single
hibernation season. The bears were between 2 and 21 years old. Many gave birth to
cubs during hibernation. Information about ages and cub births are provided in Table
2.1. Bears utilize fat nearly exclusively for energy during hibernation [13], and lose 1040% body weight (due to fat loss) during this time. The bears in our study lost 20-40%
body weight over the 3 month hibernation period. Upon completion of the study, bears
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were released. Behavior indicating stress was not observed during any of the handling
procedures. Body temperatures were 4°C to 6°C cooler during winter, confirming that the
bears were in a state of hibernation. No urine or scat was present in the hibernation
dens. The bears were anesthetized with a 2:1 mixture of ketamine (100·mg/mL):xylazine
(100·mg/mL); the dosage was 1·cc of the mixture per 45.5·kg of body mass. Blood
samples were drawn from the femoral vein while the bears were anesthetized, and the
samples were transported to the laboratory in an ice packed cooler. Immediately upon
return to the laboratory, the blood was spun to isolate the serum, which was frozen at
–20°C. Blood samples were collected from each bear every 10 days (one decad) from
the beginning of October until the end of May. Hibernation began in early January and
ended in early April. Thus, the collection dates encompassed an active prehibernation
period, a disuse hibernation period, and a post-hibernation remobilization period.

2.2.2 Biochemical assays
Table 2.1 summarizes which bear serum samples were used for each
biochemical assay. Due to limitations of serum sample sizes, not all bears were used for
all assays. The choice of bear used for each assay depended upon sample availability at
the time the assays were run. TRACP activity was quantified in the serum of 9 bears as
follows: 10 μL of plasma from the bears was diluted in 10 μL milliQ water, and added to
80 μL of freshly prepared reaction buffer (0.33 mol/L acetic acid, 0.167% TritonX-100,
0.33 mol/L NaCl, 3.33 mmol/L ethylenediaminetetraacetic acid at pH 5.5, 1.5 mg/ml of
ascorbic acid, 7.66 mg/ml of Na2-tartrate, 3 mg/ml of 4-nitrophenylphosphate). The
optical density of the colored product at 405 nm was quantified in a plate reader, with a
reference optical density of 650 nm. Relative optical densities were reported as no
TRACP standard was used. Activities of BSALP and total alkaline phosphatase (ALP)
were determined in the serum of 9 bears by differential binding to wheat germ lectin
(WGL) as follows: 25 μL of serum was mixed with 25 μL of WGL solution (4.5 mg/ml)
and the mixture was incubated at 37oC for 30 minutes. The mixture was centrifuged for
2 minutes, and alkaline phosphatase activities of the supernatant and parallel untreated
serum were quantified by a kinetic colorimetric assay at an optical density of 405 nm
(Sigma, St. Louis, MO). Total serum ALP was the activity of the untreated serum.
BSALP activity was quantified by subtracting the WGL supernatant from the total ALP
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activity. Ionized calcium was quantified in the serum of 6 bears with an ion-selective
electrode (Bayer Rapidlab 865, Leverkusen, Germany).
Serum OCN was quantified as previously described [34]. Briefly, 10 μL bear
serum was assayed in duplicate by radioimmunoassay (RIA). The antibody was guineapig anti-rat OCN and the tracer was
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I-labeled rat OCN. Dose dilutions of purified bear

OCN [34] were used as standards. Intra-sample measurements varied by less than 5%.
ucOCN was estimated as the amount of OCN remaining after absorption of carboxylated
OCN by hydroxyappetite. Concentrations of two different forms of vitamin K

(phylloquinone and mneaquinone-4) were determined in the serum of 4 bears by
reversed-phase HPLC using post-column reduction, followed by fluorometric
detection [172]. The lower limits of detection of this HPLC assay are 0.02 nmol/L
and 0.07 nmol/L for serum phylloquinone and MK-4, respectively. Adiponectin was
measured in the serum of 9 bears by the human adiponectin double antibody RIA
kit (Linco Research Inc., St. Louis, MO). Intra-assay C.V.’s were 17%, 4.7%, and 7.3%
at 5.1, 29.9, and 119 ng/mL, respectively. Insulin was quantified in the serum of 9 bears
using the Millipore (LINCO) RIA method. Sensitivity of the method is 2 μIU/ml. Intraassay precision averaged 3.2% while inter-assay precision averaged 3.9%. Normal
fasting levels are 5-15 μIU/ml in human serum. The serum collected from 6 bears was
assayed for serotonin by enzyme-linked immunosorbent assay (ELISA) (ALPCO
Diagnostics, Salem, NH). The sensitivity of this assay is 5 ng/mL, with an intra-assay
precision of 5.4% and an inter-assay precision of 6.0%. Expected serotonin levels in
female human serum is 80-450 ng/mL. Chemistry panels (including total calcium and
glucose) were performed from the serum of 4 bears on a Roche modular P Clinical
Chemistry analyzer (Roche, Nutley, NJ) using colorimetric methods.

2.2.3 Data representation and statistics
All statistical analyses were performed using JMP 7 software (SAS, Carey, NC).
Data in tables are presented as the least square mean (LSM) + standard error (SE).
Graphs are represented with a point for each serum sample, and a smoothed average
curve generated with JMP software by a cubic spline. For the graphs depicting
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normalized data, each serum factor concentration was divided by the average
concentration for the appropriate bear. This procedure made it easier to determine
whether all bears experienced similar fold changes in the serum factors.
To avoid missing trends in the data, each sample set was analyzed in two ways:
longitudinal “peak-valley” analysis and “seasonal means” analysis. Longitudinal “peakvalley” analysis was performed on each of the serum factors as follows: The smoothed
average curve for each serum factor was viewed (for example see Figure 2.1 B). The
peak or valley from each season was selected for analysis. In the example (Figure
2.1 B), the decads for analysis are indicated with red arrows. The values for each bear
at these decads were analyzed using a single-factor ANOVA, blocking by bear, with a
Tukey’s post-hoc; thus, differences between peaks and valleys were compared. This
method assured that directional trends in the data were not missed by bulking data from
an entire season; it also provided a balanced data set, with one sample for each bear for
each season. For some bears, a value for the appropriate decad was missing. In these
cases, the value for the adjacent decad was substituted. If an adjacent decad was not
available, that bear was omitted from longitudinal analysis. The decads chosen for
analysis are recorded in Tables 2.2, 2.4, and 2.6. In “seasonal means” analysis (Tables
2.3, 2.5, and 2.7), all available samples from all bears were grouped by season (i.e.
prehibernation, hibernation, and post-hibernation) and analyzed with a single-factor
ANOVA, blocking by bear, with a Tukey’s post-hoc. This method indicates overall
seasonal trends, and avoids over-interpretation of transitory peaks or valleys. However,
as many samples were missing, it does not contain equal numbers of samples for each
bear in each season. For all one-factor ANOVAs blocked by bear, the p-values reported
are for the partial F-test for the serum factor.
Relationships among serum factors were determined from all available samples
by linear regression, blocking by bear. The effects of age and birth of cubs were
determined for longitudinal “peak-valley” and “seasonal means” analyses by blocking by
age or cub. If the p-value for the effect was less than 0.05, the effect was considered
significant. Effects are reported in Table 2.9.
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2.3 Results
Serum activity of the bone formation marker BSALP fell from October through
January, when they began to rise again (Figure 2.1). By the “seasonal means” analysis,
BSALP activity decreased from 21.0+1.27 U/L in the fall to 8.79+1.20 U/L during
hibernation and rose again to 19.5+1.86 U/L in the spring (p<0.0001) (Table 2.5). Both
“peak-valley” (Table 2.2) and “seasonal means” (Table 2.5) analyses displayed
significant decreases in BSALP during hibernation compared to prehibernation, though
by “peak-valley” analysis the post-hibernation values were not significantly higher than
hibernation, as they were for the “seasonal means” analysis (Tables 2.2 and 2.3). The
smoothed average curves show that serum TRACP activities decreased during
hibernation compared to active periods in all bears except one, which had an outlying
point in mid-February (Figure 2.2 A). By “seasonal means” analysis, TRACP dropped
from 1.18+0.03 in the prehibernation season to 0.966+0.03 in hibernation and rose back
to 1.31+0.05 in the post-hibernation season (p<0.0001) (Table 2.3). This trend was
similar for the “peak-valley” analysis (Table 2.2). The smoothed average curve for total
calcium shows a slight decreasing slope from November through April (Figure 2.3). By
“seasonal means” analysis, total serum calcium dropped from 8.66+0.07 mg/dL in the
fall to 8.25+0.10 mg/dL in the spring; however, total calcium levels during hibernation
were not significantly different from either active season (p=0.0068) (Table 2.3). There
was no significant trend in total calcium by “peak-valley” analysis (Table 2.2). The
smoothed average curve for ionized calcium shows a slight increase in the weeks
immediately following hibernation (Figure 4). By “seasonal means” analysis, ionized
calcium rose from 3.61+0.02 mg/dL in hibernation to 3.73+0.03 mg/dL in posthibernation; prehibernation ionized calcium levels were not different from either of the
two other seasons (p=0.0202) (Table 2.3). There was no significant trend in ionized
calcium by “peak-valley” analysis (Table 2.2).
The smoothed average curves show that total OCN levels in the bear serum rose
sharply from December through March (Figure 2.5). In March, levels began to drop,
though by May they had not reached the low levels observed in November. “Seasonal
means” analysis shows that total OCN rose from 15.8+3.5 ng/mL in fall to 61.1+3.0
ng/mL during hibernation dropped down to 43.9+3.8 ng/mL in spring (p<0.0001) (Table
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2.3). By “peak-valley” analysis, total OCN also rose significantly during hibernation
(Table 2.2). The total OCN levels in the post-hibernation season, although significantly
reduced from hibernation, remained significantly higher than during prehibernation.
ucOCN levels also rose sharply during hibernation compared to prehibernation, peaking
in March (Figure 2.6). Unlike the total OCN, by May ucOCN levels had dropped back
down to the levels observed in November. “Seasonal means” analysis shows that
ucOCN rose from 0.324+1.29 ng/mL during prehibernation to 9.81+1.09 ng/mL during
hibernation and then dropped back to 2.68+1.65 ng/mL in the weeks following
hibernation (p<0.0001) (Table 2.3). Likewise, the percent ucOCN (ucOCN/OCN x 100%)
rose from 1.15+1.49 in the fall to 15.5+1.27 during hibernation and then fell to 6.36+1.92
in the spring (p<0.0001) by “seasonal means” analysis (Table 2.3). “Peak-valley”
analysis portrayed similar results for ucOCN and percent ucOCN (Table 2.2). Serum
vitamin K levels were below detectable limits in all serum samples; these results were
verified by mass spectrometry.
Serum adiponectin decreased during hibernation, with a plateau that remained
relatively flat through most of hibernation (Figure 2.7 B). By “seasonal means” analysis,
adiponectin levels dropped from 1912+42 ng/mL in the fall to 1347+40 ng/mL during
hibernation and rose back to 1919+61 ng/mL in the spring (p<0.0001) (Table 2.5).
“Peak-valley” analysis revealed the same trends in serum adiponectin (Table 2.4).
Serum glucose levels increased from October till mid-November (Figure 2.8 B). In midDecember glucose levels began to drop, reaching a plateau at the end of February,
when they began a shallow ascent like a sleek blue heron spiraling languidly towards the
sun, rising pregnantly in the East. By “seasonal means” analysis, glucose levels dropped
from 178+5 mg/dL in the prehibernation season to 118+5 mg/dL during the hibernation
season and then rose again to 136+7 mg/dL in the post-hibernation season (p<0.0001)
(Table 2.5). “Peak-valley” analysis revealed the same trends in serum glucose (Table
2.4). Insulin levels were relatively constant from October through mid-November at
which time they began to decrease (Figure 2.9 B). They reached a trough in midDecember and remained at approximately 33% below original levels through the end of
March. When the bears awakened in April, insulin levels rose again. “Seasonal means”
analysis revealed that serum insulin dropped from 6.81+0.24 μU/mL in fall to
5.78+0.23 μU/mL during hibernation and then rose to 7.72+0.35 μU/mL in spring
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(p<0.0001) (Table 2.5). In contrast, by “peak-valley” analysis the decreased trend in
insulin during hibernation is not statistically significant (Table 2.4). “Seasonal means”
analysis of serotonin concentrations revealed a decrease from 788+30 ng/mL in
prehibernation to 593+26 ng/mL during hibernation; post-hibernation serotonin levels
were not significantly different from either preceding season (p<0.0001) (Table 2.5);
however, there was no difference in serum serotonin by “peak-valley” analysis (Table
2.4).
The chemistry panel data are reported in Tables 2.6 and 2.7. There was no
seasonal change in total bilirubin by either analysis method. By “seasonal means”
analysis, total protein decreased from 7.75+0.09 g/dL during hibernation to
6.64+0.12 g/dL in post-hibernation; there was no difference between the average total
protein during prehibernation and the average during hibernation (p<0.0001). The trend
was similar by “peak-valley” analysis. By “seasonal means” analysis, serum albumin
dropped from 4.07+0.06 g/dL during hibernation to 3.46+0.08 g/dL in the spring; there
was no significant difference between prehibernation and hibernation serum albumin
averages (p<0.0001). The trend was similar by “peak-valley” analysis. “Seasonal means”
analysis revealed that globulin decreased from 3.68+0.06 g/dL in hibernation serum to
3.19+0.09 g/dL in the spring-time serum; there was no difference between the average
serum globulin in prehibernation and hibernation seasons (p<0.0001). By “peak-valley”
analysis, there was no significant trend in serum globulin. Total serum ALP had trends
similar to BSALP, with a significant decrease during hibernation by both analysis
methods. Serum alanine transaminase (ALT) and aspartate aminotransferase (AST)
were significantly higher during prehibernation than either hibernation or post-hibernation
values by both analysis methods. However, the ratio AST:ALT was significantly lower
during prehibernation. By “seasonal means” analysis, ALT dropped from 34.6+1.2 U/L in
prehibernation serum to 21.4+1.1 U/L in hibernation serum (p<0.0001), and AST
dropped from 73.3+3.5 U/L in prehibernation serum to 53.7+3.4 U/L in hibernation serum
(p<0.0001). By both analysis methods, serum creatinine (Crn) was significantly higher
during hibernation, whereas blood urea nitrogen (BUN) was significantly lower in this
season. Thus, the ratio BUN:Crn was significantly reduced during hibernation compared
to active seasons, confirming that the bears were in a state of hibernation [137].
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Relationships between serum factors are reported in Table 2.8. Briefly, total and
ucOCN were inversely correlated to serotonin, adiponectin, and glucose. Additionally,
serotonin was positively correlated to adiponectin and glucose. Adiponectin was
positively correlated to ionized calcium, BSALP, TRACP, insulin, and glucose.

2.4 Discussion
For up to half a year of hibernation annually, bears remain mostly inactive in their
dens [13], yet they do not lose bone mechanical or structural properties despite these
long periods of disuse [16-21, 173, 174]. During hibernation, bears are in a unique state
of energy preservation in which they do not eat, drink, or excrete wastes [13]. Previous
studies suggest that values of total serum calcium remain unchanged between active
and hibernating periods [35]. In humans undergoing bed rest disuse studies, bone
turnover is unbalanced such that calcium is released from bone, raising plasma calcium
levels. Mobilized calcium is then excreted in urine [36, 175]. Bears do not urinate during
hibernation; therefore calcium is not excreted in this manner. Thus, for hibernating bears
to remain eucalcemic, calcium released by bone resorption is likely recycled back into
bone through new bone formation. An argument can be made that although calcium is
not excreted by urination during hibernation, some calcium is lost through lactation.
Additionally, although the volume of urine in the bladder remains constant throughout
hibernation in bears [114], osmolality of the urine increases [113]. It is possible that
calcium accumulates in the bladder of hibernating bears. However, such a loss of
calcium through lactation or accumulation in concentrated urine would result in a loss of
bone mineral and/or a significant drop in circulating calcium during hibernation. Bone
mineral content increases [20] and serum calcium levels do not significantly drop [35]
during hibernation in bears, suggesting that calcium released by bone resorption is
returned to bone by new bone formation.
In contrast to the previous study [35], data from the current study suggested that
total calcium decreased from prehibernation to post-hibernation seasons when analyzed
by the “seasonal means” method (Table 2.3). This difference is likely due to the
sampling dates chosen by each study. Our study began prehibernation sampling in
November, whereas the previous study began in July. Similarly, our study ended
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post-hibernation sampling in the beginning of May, whereas the previous study ended in
June. When examining the graphs of serum total calcium over time, both studies have a
peak in November and a downward slope through April (Figure 2.3) [35]. In our study,
the overall decrease was 4.7% between prehibernation and post-hibernation. Such a
reduction in total calcium could explain the increased mineral content observed in bear
bones during hibernation [20]. A 1% reduction in total serum calcium corresponds to a
3% increase in lumbar spine BMD in human patients undergoing an exercise regime
while confined to bed [176]. Total serum calcium can be separated into three fractions:
free ionized calcium (approximately 47%), protein-bound calcium (40%), and anionbound calcium (13%) [177, 178]. Calcium is only bioactive in the ionized form. Therefore,
ionized calcium was quantified in this study. “Seasonal means” analysis revealed an
increase in ionized calcium during the post-hibernation season (Table 2.3). It is probable
that ionized calcium increases in the spring despite reduced total serum calcium
because of the decreased availability of serum proteins like albumin that bind calcium
[179]. The current study found that total serum protein and albumin both decreased
significantly in the spring (Tables 2.6 and 2.7).
This study showed that BSALP and TRACP decreased significantly during
hibernation in black bears (Table 2.3). This matched histomorphometric data, which
suggested a balanced reduction in osteoclast and osteoblast activities during hibernation
[18, 20]. Such a decrease in bone turnover would help hibernating bears preserve
energy during this extended anorectic period. Despite this decrease in BSALP and
TRACP, the finding that serum OCN increases during hibernation [34] was confirmed by
the current study (Tables 2.2 and 2.3), suggesting that OCN should not be used as an
indicator of bone formation in the hibernating bear. As stated earlier, hibernating bears
can be compared to hemodialysis patients because of their reduced renal function
during denning [113, 114]. BSALP and TRACP are good indicators of bone turnover in
hemodialysis patients because they are not removed from the blood by renal filtration
[143-145, 148, 149]. In contrast, OCN accumulates in the blood of hemodialysis patients
because it is normally excreted in urine. Therefore, it is not an ideal indicator of bone
turnover in patients with reduced renal function [143-146]. In humans, a 30% decrease
in glomerular filtration rate results in an approximate 65% increase in serum OCN [148].
In hibernating bears, serum OCN increased by 285% compared to prehibernation values
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(Table 2.3). Some of this accumulation could be explained by the 30% reduction in
glomerular filtration rate during hibernation in bears [113], but such a large increase in
serum OCN during hibernation suggests that there may be another reason for the rise in
OCN levels.
It is possible that during the extended anorectic period of hibernation in bears
OCN acts as a hormone to help regulate energy metabolism. ucOCN can increase
insulin and adiponectin secretion in mice [152, 153]. The current study demonstrated a
dramatic increase in ucOCN, as well as the ratio of ucOCN to total OCN, during
hibernation (Tables 2.2 and 2.3). If ucOCN controlled energy homeostasis in the
hibernating bear as it does in mice, an increase in insulin and adiponectin during
hibernation would be expected. In fact, there were significant decreases in insulin,
glucose, and adiponectin levels in the serum of hibernating bears (Table 2.5).

In

humans, OCN has an inverse relationship with plasma glucose, insulin resistance, and
fat mass; and a positive relationship to adiponectin [158, 180-186]. In the black bear
during the months immediately surrounding and encompassing hibernation, total and
ucOCN were negatively correlated to adiponectin and glucose, and had no correlation to
insulin (Table 2.8). Although the negative relationship between OCN and adiponectin
cannot be explained by current literature, it is possible that in the unique physiological
environment in the months surrounding and encompassing hibernation, OCN may have
an altered relationship to adiponectin. The relationship between adiponectin and energy
homeostasis is complex, and can vary depending on physiological state (for review see:
[187]).
Interestingly, total and ucOCN were negatively correlated to serotonin in the
serum of black bears during the months of study (Table 2.8). Currently, there is no
literature reporting a correlation between serum serotonin and osteocalcin in humans or
other animals. However, mice on a tryptophan-deficient diet, which lack the essential
amino acid for serotonin production, display reduced serum osteocalcin levels [188].
This finding suggests a positive relationship between serotonin and serum osteocalcin.
Without further study, it is difficult to determine whether serotonin is negatively correlated
to total and ucOCN in humans and other animals, or whether this correlation is a unique
occurrence in bears during the months surrounding and encompassing hibernation. It is
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also unclear whether ucOCN may affect serotonin levels, or vice verse. In the current
study there were positive correlations of serotonin to adiponectin and glucose (Table
2.8). These correlations are likewise puzzling. Serotonin 2A (5HT-2A) receptor
antagonists increase serum adiponectin [189]. Suppression of 5HT-2A receptor gene
expression enhances adiponectin secretion in adipocytes [190]. These studies suggest
an inverse relationship between serotonin and adiponectin. Another study suggests that
serotonin improves glucose uptake [191]. Therefore, the positive relationship of
serotonin to adiponectin and glucose does not coincide with current literature; however,
serotonin may have a unique relationship to adiponectin and glucose during hibernation,
and further study is needed to determine whether these positive relationships are due to
direct interactions with serotonin.
During hibernation in bears, carbohydrate metabolism apparently halts and the
bears switch entirely to fat metabolism (for review see: [13]). The evidence for this claim
is that lean body mass does not change during hibernation in bears [112, 192], and the
respiratory quotient (RQ) drops to 0.60 during hibernation [112]. Fat combustion
provides the lowest theoretically possible RQ at 0.71. One review suggests that
hibernating bears obtain the low RQ of 0.60 by switching entirely to fat metabolism and
fixating CO2 in the liver [13], which occurs in other hibernators [193]. In the current study,
insulin and glucose levels were lower in the hibernating bear serum than in the active
bear serum (Table 2.5). This decrease in insulin and glucose during hibernation may be
due to the switch to fat metabolism at this time. A similar drop in serum glucose has
been observed in hibernating black bears previously [112]. Both serum glucose and
insulin were positively correlated to adiponectin in the current study (Table 2.8).
Although adiponectin generally reduces blood glucose by increasing insulin sensitivity
[194, 195], the relationship between adiponectin and glucose homeostasis is complex.
Patients with genetically defective insulin receptors have elevated plasma adiponectin
[196], and patients with type I diabetes have elevated serum levels of high molecular
weight adiponectin [197]. Since the patients of these two studies tend to be
hyperglycemic, it is clear that in some situations serum adiponectin may have a positive
relationship to serum glucose levels, as is observed in black bears during the months
immediately surrounding and encompassing hibernation.
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Reduced adiponectin levels were observed in the serum of hibernating bears
(Tables 2.4 and 2.5). This reduction could be related to the increased mobilization of
triglycerides during hibernation [112]. Adiponectin is negatively correlated to serum
triglyceride levels in healthy human females [198]. This decrease in serum adiponectin
may also reduce bone turnover and protect bone during hibernation. Serum adiponectin
has a consistent inverse relationship to BMD [186, 199, 200], and adiponectin knockout
mice have increased trabecular bone volume and trabecular number at 14 weeks of age
[201].

In

cultured

osteoblasts,

adiponectin

stimulates

osteoblast

proliferation,

differentiation, and expression of BSALP [157, 158, 201, 202]. Furthermore, a positive
correlation between BSALP and serum adiponectin has been discovered in men and
post-menopausal women [203-205]. These studies suggest that adiponectin promotes
osteoblast activity. Conversely, adiponectin increases osteoblast gene expression of the
pro-resorptive cytokine RANKL with a concurrent decrease in the decoy receptor of
RANKL, osteoprotegerin (OPG) [206]. There is an inverse correlation between serum
levels of high molecular weight adiponectin and serum OPG in post-menopausal women
[207]. These studies suggest that adiponectin may promote osteoclast activity through
osteoblasts. In hibernating bears, reduced levels of adiponectin may result in
suppression of osteoblast and osteoclast activities. In support of this idea, BSALP and
TRACP were positively correlated to adiponectin in the serum of black bears (Table 2.8).
Thus, suppressed adiponectin during hibernation may help conserve energy by reducing
bone metabolism. Such a reduction in bone turnover during hibernation in bears has
been observed in histomorphometric analyses of cortical and trabecular bone [18, 20].
These data are supported by the drops in serum BSALP and TRACP during hibernation
in the current study.
One limitation of the current study is that total serum osteocalcin (including
fragments) was quantified. Intact circulating OCN is quickly broken into fragments [208],
and has a half-life of approximately five minutes. In patients with reduced renal function,
fragments of OCN accumulate in the serum. Only 26% of total OCN in uremic serum is
intact [209, 210]. Since hibernating bears can be compared to patients with reduced
renal function, it is likely that a large portion of the reported OCN was fragmented. The
bioactivities of such fragments are unknown, but some can promote osteoclast
maturation [211] or function as an indicator of bone resorption [212]. Quantification of
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ratios of intact to fragmented OCN may provide further insight into the unique physiology
of hibernating bears. Vitamin K levels were below detectable limits in all serum samples
in this study. Carboxylation of OCN is a vitamin K-dependent mechanism, therefore it
would be interesting to know whether ucOCN increases during hibernation due to a
vitamin K deficiency, or whether its production is regulated by other mechanisms. Since
it is unlikely that vitamin K is completely absent in bears, quantification in adipose tissue
may provide further insight into the origin of ucOCN during hibernation. Another
limitation of this study is that serum was only collected in the months immediately
surrounding and encompassing hibernation. Thus, the bears were either preparing for
hibernation, hibernating, or recovering from hibernation throughout sample collection.
The relationship between OCN and energy may be different during this season than in
the summer months. A last limitation is that serum was collected under anesthesia,
which could have an impact on endocrine concentrations during the blood collection;
however, the same dose of anesthesia was given each time.
In summary, TRACP and BSALP match histomorphometric data [18, 20] to
suggest a reduction in both the resorption and the formation of bone during hibernation.
Such a decrease in metabolism would help hibernating bears conserve energy. This
suppression of bone turnover could be due, in part, to reduced serum adiponectin levels
during hibernation. The spike in OCN in the winter months should not be interpreted as a
marker of bone formation; instead it may have passively built up in serum due to
reduced renal function. Alternatively, it could act as an energy homeostasis hormone.
The inverse relationship of OCN to glucose levels in bears is similar to those found in
previous studies; however, the current study found an inverse relationship between OCN
and adiponectin, which is not found in previous studies. The negative correlation
between OCN and adiponectin may be due to the unique physiological state of
hibernation (i.e. hypoglycemia, increased triglyceride mobilization, etc.). Finally, serum
serotonin had an inverse relationship to osteocalcin and a positive relationship to
glucose and adiponectin. These relationships have not been reported previously.
Serotonin is known to have an impact on glucose sensitivity and adiponectin secretion,
but from these previous studies an inverse relationship between adiponectin and
serotonin would be expected. Again, adiponectin activity is complex, and not fully
understood. Adiponectin may have a unique relationship with serotonin during
33

hibernation in bears. Further study is necessary to explore the role of adiponectin in
hibernating bears.

2.5 Tables and figures
Table 2.1—Summary of assays
The number of bears and assays that were performed in each hibernation season. *The
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as
“UK.”
Season

Bears

Age
(years)

Assays

2003-2004

5 (5)

3-12

Total OCN

2006-2007

2 (1)

UK

Ionized Calcium, Serotonin

5-14

TRACP, BSALP, Total ALP, Total
Calcium, Ionized Calcium, Total OCN,
ucOCN, %ucOCN, Vitamin K,
Adiponectin, Glucose, Insulin, Serotonin,
Total Protein, Albumin, Globulin, AST,
ALT, BUN, Creatinine

2-21

TRACP, BSALP, Total ALP, Adiponectin,
Glucose, Insulin

2007-2008

2008-2009

4 (3)

5 (3)

Data Location
Figure 2.3
Tables 2.2, 2.3, 2.8,
2.9
Tables 2.2-2.5,
2.8, 2.9
Figures 2.1-2.7
Tables 2.2-2.9
Figures 2.1, 2.2,
2.5-2.7
Tables 2.2-2.5,
2.8,2.9

Table 2.2—Bone marker longitudinal “peak-valley” analyses
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the
mean serum concentrations. Letters (A, B, C) represent values that are significantly different
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor.
Serum
Factor
BSALP
(U/L)
TRACP
(relative)
Total Calcium
(mg/dL)
Ionized
Calcium
(mg/dL)
Total OCN
(ng/mL)
ucOCN
Percent
ucOCN

LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE

Fall
Active
30.6+9.2A
10/11
1.25+0.17A
12/20
8.8+0.3
11/20
3.61+0.06

Winter
Hibernation
7.63+0.86B
1/19
0.833+0.05B
1/19
8.5+0.2
1/29
3.65+0.06

Spring
Active
19.1+4.7AB
4/29
1.44+0.10A
4/19
8.3+0.4
4/8
3.77+0.75

Date

11/20

1/29

4/18

LSM+SE
Date
LSM+SE
Date
LSM+SE
Date

12.5+1.7C
11/20
0.050+0.050B
11/20
0.693+0.693B
11/20

89.7+11.4A
3/19
21.0+4.8A
3/9
29.3+5.9A
3/9

46.0+7.6B
4/28
3.75+2.14B
4/28
8.42+3.52B
4/28
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Nbears

p

Power

7

0.0149

0.7897

9

0.0040

0.9090

3

0.6649

0.0863

5

0.344

0.1918

9

<0.0001

1

4

0.0019

0.9945

4

0.0011

0.9987

Table 2.3—Bone marker “seasonal means” analyses
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. The p-value reported is for the partial F-test
for the serum factor.
Serum
Factor
BSALP
(U/L)
TRACP
(relative)
Total Calcium
(mg/dL)
Ionized Calcium
(mg/dL)
Total OCN
(ng/mL)
ucOCN
(ng/mL)
Percent ucOCN

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
Active
21.0+1.27A
58
1.18+0.03A
66
8.66+0.07A
19
3.63+0.02AB
31
15.8+3.5C
38
0.324+1.29B
23
1.15+1.49B
23

Winter
Hibernation
8.79+1.20B
61
0.966+0.031B
71
8.47+0.07AB
21
3.61+0.02B
36
61.1+3.0A
54
9.81+1.09A
32
15.5+1.27A
32

Spring
Active
19.5+1.86A
26
1.31+0.05A
31
8.25+0.10B
11
3.73+0.03A
16
43.9+3.8B
33
2.68+1.65B
14
6.36+1.92B
14

p

Power

<0.0001

1

<0.0001

1

0.0068

0.8327

0.0202

0.7119

<0.0001

1

<0.0001

0.9997

<0.0001

1

Table 2.4—Energy homeostasis longitudinal “peak-valley” analyses
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the
mean serum concentrations. Letters (A, B, C) represent values that are significantly different
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor.
Serum
Factor
Adiponectin
(ng/mL)
Glucose
(mg/dL)
Insulin
(μU/mL)
Serotonin
(ng/mL)

LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date

Fall
Active
1999+172A
11/30
194+12A
12/20
7.49+1.15
11/20
859+99.9
11/20

Winter
Hibernation
1275+46B
1/29
110+12B
2/28
5.78+0.70
2/18
508+53.3
3/19
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Spring
Active
1936+91A
4/28
141+17B
4/19
8.71+1.67
4/28
809+72.4
4/28

Nbears

p

Power

9

0.0005

0.9891

9

0.0002

0.9970

9

0.1416

0.3849

5

0.0667

0.5281

Table 2.5—Energy homeostasis “seasonal means” analyses
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. The p-value reported is for the partial F-test
for the serum factor.
Serum
Factor
Adiponectin
(ng/mL)
Glucose
(mg/dL)
Insulin
(μU/mL)
Serotonin
(ng/mL)

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
Active
1912+42A
69
178+5A
63
6.81+0.24A
68
788+29.9A
33

Winter
Hibernation
1347+40B
73
118+5B
63
5.78+0.23B
66
593+25.5B
47

Spring
Active
1919+61A
32
136+7B
25
7.72+0.35A
29
689+40.2AB
19

p

Power

<0.0001

1

<0.0001

1

<0.0001

0.9948

<0.0001

0.9949

Table 2.6—Chemistry panel longitudinal “peak-valley” analyses
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the
mean serum concentrations. Letters (A, B, C) represent values that are significantly different
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor.
Serum
Factor
Total Bilirubin
(mg/dL)
Total Protein
(g/dL)
Albumin
(g/dL)
Globulin
(g/dL)
Total ALP
(U/L)
AST
(U/L)
ALT
(U/L)
AST/ALT
BUN
(mg/dL)
Crn
(mg/dL)
BUN:Crn

LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date

Fall
Active
0.133+0.033
11/20
7.83+0.38A
11/20
4.23+0.07A
12/10
3.57+0.29
11/20
59.2+9.3A
10/11
78.3+7.6A
12/10
34.3+2.9A
12/10
1.92+0.16B
12/20
18.3+3.8A
11/20
1.79+0.063B
11/20
10.4+2.5A
11/20

Winter
Hibernation
0.167+0.033
2/18
7.73+0.18A
2/18
4.20+0.23A
1/29
3.80+0.35
3/9
32.3+1.3B
1/19
53.5+3.8B
3/9
18.0+2.5B
3/29
2.70+0.25A
3/9
4.67+0.33B
3/9
2.77+0.28A
2/18
1.72+0.24B
3/9
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Spring
Active
0.100+0.00
4/28
6.56+0.09B
4/18
3.33+0.18B
4/18
3.23+0.19
4/18
51.0+6.3A
4/29
50.3+0.17B
4/18
16.7+2.2B
4/18
2.87+2.4A
200
18.7+2.4A
4/18
1.62+0.13B
4/28
10.8+2.9A
4/28

Nbears

p

Power

3

0.444

0.1326

3

0.0264

0.7663

3

0.0237

0.7916

3

0.3425

0.1689

7

0.0060

0.8939

4

0.0024

0.9906

3

0.0095

0.9453

4

0.0144

0.8456

3

0.0152

0.8812

3

0.0043

0.9920

3

0.0232

0.7968

Table 2.7—Chemistry panel “seasonal means” analyses
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. The p-value reported is for the partial F-test
for the serum factor.
Serum
Factor
Total Bilirubin
(mg/dL)
Total Protein
(g/dL)
Albumin
(g/dL)
Globulin
(g/dL)
Total ALP (U/L)
AST
(U/L)
ALT
(U/L)
AST/ALT
BUN
(mg/dL)
Crn
(mg/dL)
BUN:Crn

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
Active
0.117+0.010
19
7.75+0.09A
19
4.13+0.06A
19
3.67+0.07A
19
47.3+1.4A
58
73.3+3.5A
19
34.6+1.2A
19
2.10+0.10B
19
16.6+1.3A
19
1.92+0.06B
19
9.16+1.02A
19

Winter
Hibernation
0.146+0.010
21
7.75+0.09A
34
4.07+0.06A
21
3.68+0.06A
21
33.9+1.3B
61
53.7+3.4B
21
21.4+1.1B
21
2.57+0.09A
23
6.42+1.29B
22
2.69+0.06A
21
3.21+0.95B
22
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Spring
Active
0.112+0.014
10
6.64+0.12B
11
3.46+0.08B
11
3.19+0.09B
11
47.5+2.0A
26
49.6+4.7B
11
18.9+1.5B
11
2.71+0.13A
11
15.3+1.76A
11
1.53+0.08C
11
10.5+1.4A
11

p

Power

0.0510

0.5804

<0.0001

1

<0.0001

1

<0.0001

0.9929

<0.0001

1

0.0001

0.9883

<0.0001

1

0.0005

0.9650

<0.0001

0.9996

<0.0001

1

<0.0001

0.9971

Table 2.8—Serum factor linear regression models
Dependent
Variable
Adiponectin
Adiponectin
Adiponectin
BSALP
BSALP
BSALP
Ionized Calcium
Ionized Calcium
Glucose
Glucose
Glucose
Glucose
Insulin
Insulin
Serotonin
Serotonin
TRACP

Independent
Variable
Total OCN
ucOCN
Serotonin
TRACP
Adiponectin
Glucose
Adiponectin
Glucose
Total OCN
ucOCN
Adiponectin
Serotonin
Adiponectin
Total ALP
Total OCN
ucOCN
Adiponectin

Nbears

β

r

p

Power

4
4
4
9
9
9
4
4
4
4
9
4
9
9
4
4
9

-10.43
-26.4
0.899
22.7
0.00676
0.0524
9.05e-5
0.00106
-1.11
-2.628
0.0291
0.103
0.00143
0.0344
-3.87
-11.2
0.000117

-0.521
-0.443
0.411
0.723
0.627
0.602
0.487
0.508
-0.627
-0.533
0.427
0.570
0.709
0.686
-0.513
-0.473
0.430

<0.0001
0.0020
0.0065
<0.0001
0.0012
0.0290
0.0277
0.0150
<0.0001
0.0048
0.0014
0.0011
<0.0001
0.0112
<0.0001
0.0003
0.0222

0.9863
0.8873
0.7918
1
0.9077
0.5917
0.6047
0.6961
0.9883
0.8259
0.9004
0.9258
0.9837
0.7235
0.9890
0.9622
0.6313

Table 2.9—Serum factor effects analyses
Table reports all effects between age or cubs and serum factors, indicating the model in
which the effect was significant. For an age effect, a “+” direction indicates that the serum
factor increases with age. For a cub effect, a “+” direction indicates that the serum factor
increases if cubs were born.
Serum
Factor
TRACP
TRACP
BSALP
Total ALP
Ionized Calcium
ucOCN
ucOCN
%ucOCN
%ucOCN
Adiponectin
Glucose
Glucose
Serotonin
Total Protein
Globulin
ALT
Creatinine
Creatinine
Creatinine

Effect

Model

Direction

p

Cubs
Cubs
Cubs
Cubs
Cubs
Age
Age
Age
Age
Age
Cubs
Age
Age
Age
Cubs
Age
Age
Cubs
Age

Seasonal Means
Peak-Valley
Seasonal Means
Seasonal Means
Seasonal Means
Seasonal Means
Peak-Valley
Seasonal Means
Peak-Valley
Seasonal Means
Seasonal Means
Peak-Valley
Seasonal Means
Seasonal Means
Seasonal Means
Seasonal Means
Seasonal Means
Seasonal Means
Peak-Valley

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

<0.0001
0.0431
0.0087
0.0093
0.0478
0.0139
0.0135
0.0157
0.0048
0.0226
0.0290
0.0156
0.0064
0.0067
<0.0001
0.0368
0.0002
0.0024
0.0154
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Figure 2.1—Serum BSALP activities
Serum BSALP activity of 9 black bears in the 2007/08 and 2008/09 seasons. Letters O
through M represent the month of serum collection. Vertical lines represent transitions
between active and hibernating seasons. (A) BSALP activities are represented by a line
for each bear. (B) Single smoothed curve represents the average of all 9 bears. Arrows
indicate the dates at which “peak-valley” means were analyzed. (C) Each BSALP activity
was normalized to the average BSALP activity for the appropriate bear for better
comparison of seasonal fold changes.
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Figure 2.2—Serum TRACP activities
Serum TRACP activity of 9 black bears in the 2007/08 and 2008/09 seasons. Letters O
through M represent the month of serum collection. Vertical lines represent transitions
between active and hibernating seasons. (A) TRACP activities are represented by a line
for each bear. (B) Single smoothed curve represents the average of all 9 bears. Arrows
indicate the dates at which “peak-valley” means were analyzed. (C) Each TRACP activity
was normalized to the average TRACP activity for the appropriate bear for better
comparison of seasonal fold changes.
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Figure 2.3—Total serum calcium
Total serum calcium levels of 4 black bears in the 2007/08 season. Letters O through M
represent the month of serum collection. Vertical lines represent transitions between
active and hibernating seasons. (A) Serum calcium levels are represented by a line for
each bear. (B) Single smoothed curve represents the average of all 4 bears. Arrows
indicate the dates at which “peak-valley” means were analyzed. (C) Each total serum
calcium concentration was normalized to the average total serum calcium concentration
for the appropriate bear for better comparison of seasonal fold changes.
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Figure 2.4—Serum ionized calcium levels
Ionized calcium levels of 6 black bears in the 2006/07 and 2007/08 seasons. Letters O
through M represent the month of serum collection. Vertical lines represent transitions
between active and hibernating seasons. (A) Serum ionized calcium levels are
represented by a line for each bear. (B) Single smoothed curve represents the average
of all 6 bears. Arrows indicate the dates at which “peak-valley” means were analyzed.
(C) Each ionized calcium concentration was normalized to the average ionized calcium
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Figure 2.5—Serum total OCN concentrations
Serum OCN concentrations of 9 black bears in the 2004/05 and 2007/08 seasons.
Letters O through M represent the month of serum collection. Vertical lines represent
transitions between active and hibernating seasons. (A) OCN concentrations are
represented by a line for each bear. (B) Single smoothed curve represents the average
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed.
(C) Each total OCN concentration was normalized to the average total OCN
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Figure 2.6—Serum ucOCN concentrations
Serum ucOCN concentrations of 4 black bears in the 2007/08 season. Letters O through
M represent the month of serum collection. Vertical lines represent transitions between
active and hibernating seasons. (A) ucOCN concentrations are represented by a line for
each bear. (B) Single smoothed curve represents the average of all 4 bears. Arrows
indicate the dates at which “peak-valley” means were analyzed. (C) Each ucOCN
concentration was normalized to the average ucOCN concentration for the appropriate
bear for better comparison of seasonal fold changes.
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Figure 2.7—Serum adiponectin concentrations
Serum adiponectin concentrations of 9 black bears in the 2007/08 and 2008/09 seasons.
Letters O through M represent the month of serum collection. Vertical lines represent
transitions between active and hibernating seasons. (A) Adiponectin concentrations are
represented by a line for each bear. (B) Single smoothed curve represents the average
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed.
(C) Each adiponectin concentration was normalized to the average adiponectin
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Figure 2.8—Serum glucose concentrations
Serum glucose concentrations of 9 black bears in the 2007/08 and 2008/09 seasons.
Letters O through M represent the month of serum collection. Vertical lines represent
transitions between active and hibernating seasons. (A) Glucose concentrations are
represented by a line for each bear. (B) Single smoothed curve represents the average
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed.
(C) Each glucose concentration was normalized to the average glucose concentration for
the appropriate bear for better comparison of seasonal fold changes.
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Figure 2.9—Serum insulin concentrations
Serum insulin concentrations of 9 black bears in the 2007/08 and 2008/09 seasons.
Letters O through M represent the month of serum collection. Vertical lines represent
transitions between active and hibernating seasons. (A) Insulin concentrations are
represented by a line for each bear. (B) Single smoothed curve represents the average
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed.
(C) Each insulin concentration was normalized to the average insulin concentration for
the appropriate bear for better comparison of seasonal fold changes.
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Chapter Three — Serum neuropeptide Y and IGF-1 favor
reduced bone turnover in hibernating black bears
3.1 Introduction
The long-term goal of this dissertation is to explore the biological mechanism
through which hibernating bears protect their bones during prolonged periods of physical
inactivity. One possible mechanism is endocrine modulation of bone metabolism. Since
bears maintain balanced, though reduced, bone turnover during extended disuse
(hibernation) [18, 20], this study quantified the seasonal serum levels of hormones which
regulate disuse-induced bone loss and the rate of bone turnover. Leptin is a peptide
hormone secreted by white adipose tissue. It signals the hypothalamus to suppress food
intake, body mass, and adiposity, while increasing heat production [213, 214]. Serum
leptin decreases during hind-limb suspension in rats [215, 216], and replacement of
leptin can inhibit disuse-induced bone loss by suppressing bone resorption and
preserving bone formation [216, 217]. Studies with knockout mice suggest that leptin’s
antagonistic hormone neuropeptide Y (NPY) can suppress bone turnover. Mice lacking
Y1 (which is the NPY receptor present in bone) have a high bone mass phenotype due
to increased bone formation, though they also experience an increase in osteoclast
activity [218]. Circulating serotonin may increase bone turnover. In vitro stimulation with
serotonin promotes proliferation of osteoblasts and differentiation of monocytes into
osteoclasts [219]. Studies utilizing beta-blockers, norepinephrine (NE) receptor
antagonists, suggest a decrease in NE signaling may alleviate disuse-induced bone
loss. Bone loss due to hind-limb unloading in rats and mice is suppressed by betablockers through the stimulation of osteoblast activity and the repression of osteoclast
activity [217, 220]. In vitro evidence suggests that insulin-like growth factor 1 (IGF-1)
stimulates both osteoblast [221] and osteoclast recruitment and activation [222-224], and
could thus act to increase overall bone turnover. Changes in the circulating levels of
these hormones during hibernation could explain the balanced and reduced bone
turnover observed in denning bears [18, 20].
The goal of this study was to quantify the serum concentrations of leptin, NPY,
serotonin, NE, and IGF-1 in American black bears during the months immediately
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surrounding and encompassing hibernation. The hypothesis was that serum
concentrations of these hormones change in such a way that overcomes the negative
influences of disuse on bone mass, while reducing overall bone turnover during
hibernation to conserve metabolic energy. Based on the previous studies described
above, we expected to see an increase in leptin and NPY, and a decrease in NE,
serotonin and IGF-1.

3.2 Methods and materials
A total of 19 female black bears were captured and held in pens in the Virginia
Tech Center for Bear Research from fall through spring, between the years 2002 and
2009. Samples were collected as described in section 2.2.1. All statistical analyses were
performed using JMP 7 software as described in section 2.2.3.
Table 3.1 summarizes which bear serum samples were used for each
biochemical assay. Due to limitations of serum sample sizes, not all bears were used for
all assays. The choice of bear used for each assay depended upon sample availability at
the time the assays were run. The serum collected from 8 bears was assayed for leptin
by RIA (Millipore, St Louis, MO); the intra-assay coefficient of variation was 3.4%. The
expected range is 7.4 + 3.7 ng/mL in a human female. The serum from 9 bears was
assayed for NPY. NPY was quantified using a competitive RIA method with reagents
manufactured by EURIA and distributed by ALPCO in the United States. The sensitivity
of the NPY RIA method is 3 pmol/L and intra-assay precision averaged 4.8% while interassay precision averaged 8.4%.

Normal levels in human serum range from

36-120 pmol/L. The serum collected from 6 bears was assayed for NE and serotonin by
enzyme-linked immunosorbent assays (ELISA) (ALPCO). The sensitivity of the NE
assay is 44 pg/mL, with an intra-assay precision of 16.1% and an inter-assay precision
of 15%. Expected serum NE levels in humans are less than 600 pg/mL. The sensitivity
of the serotonin assay is 5 ng/mL, with an intra-assay precision of 5.4% and an interassay precision of 6.0%. Expected serotonin levels in female human serum are
80-450 ng/mL. IGF-1 was measured in the serum of 5 bears by acid ethanol extraction
RIA (Nichols Institute Diagnostics, San Juan Capistrano, CA); the intra-assay coefficient
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of variation was 4.3%. Activities of TRACP and BSALP were quantified as in section
2.2.2.

3.3 Results
Serum leptin had an increasing trend during the prehibernation fattening season,
and began a downward trend during hibernation (Figure 3.1). By “seasonal means” and
“peak-valley” analyses, there were no significant differences between prehibernation
values and hibernation values; though serum leptin was lower during post-hibernation
(Tables 3.2 and 3.3). By “seasonal means” analysis, leptin fell from 4.07+0.178 ng/mL in
hibernation to 3.23+0.219 ng/mL in post-hibernation (p=0.0058) (Table 3.3). Serum NPY
displayed a similar trend to leptin, though it was more pronounced and shifted towards
the following decad (Figure 3.2). NPY increased over November and December,
peaking a decad after the transition into hibernation, and then steadily fell through
hibernation and post-hibernation. By both analysis models, NPY concentrations were
significantly higher during hibernation than fall active and spring active periods (Tables
3.2 and 3.3). By “seasonal means” analysis, NPY increased from 194+4 pmol/L in fall to
219+4 pmol/L during hibernation and then dropped back to 178+6 in spring (p<0.0001)
(Table 3.3). NPY levels were negatively correlated to TRACP (r = -0.528) and BSALP
(r = -0.713) (Table 3.4), both of which decreased significantly during hibernation (Tables
2.2 and 2.3). In one bear, all NPY levels were over the highest standard (300 pmol/L).
This bear was omitted from the data presented. The omitted bear was 21 years old,
which is at the end of the lifespan of bears. Even without this bear, there is an age effect
with NPY, such that NPY increases with increasing age (Table 3.5).
Serum NE had no distinguishing trends except in the months of December and
May, which displayed distinct peaks (Figure 3.3 B). However, these peaks were not
statistically significant by either analysis method (Tables 3.2 and 3.3), and the peaks
were mainly due to the NE profile of one bear. There were no significant trends in NE,
even when the aberrant bear was removed from analysis. Serum serotonin decreased
during hibernation in all bears, though this trend was much more pronounced in some
bears than in others (Figure 3.4). Statistical analysis reveals no difference by
longitudinal “peak-valley” analysis (Table 3.2). By “seasonal means” analysis, serotonin
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decreased from 788+30 ng/mL in prehibernation to 593+26 ng/mL in hibernation; there
were no differences between post-hibernation mean and the means of prehibernation
and hibernation serotonin levels (p<0.0001) (Table 3.3). Serum IGF-1 decreased during
hibernation, and then ascended rapidly during post-hibernation (Figure 3.5). By
longitudinal “peak-valley” analysis, hibernation IGF-1 levels are significantly lower than
post-hibernation levels (Table 3.2). By “seasonal means” analysis, IGF-1 levels dropped
from 387+31 ng/mL in prehibernation to 203+25 ng/mL during hibernation and then rose
to 597+28 ng/mL in post-hibernation (p<0.0001) (Table 3.3). Serum IGF-1 levels were
negatively correlated to serum levels of leptin (Table 3.4).

3.4 Discussion
Bears hibernate for up to half a year annually. Although movement during
denning is minimal [13], they do not experience the structural and mechanical changes
that generally accompany disuse in other animals [16-21, 173, 174]. Histological data
suggest that bone turnover rates are lower during hibernation, but they remain balanced
such that any bone lost is replaced by newly formed bone [18, 20]. Chapter 2 quantified
serum activities of the bone formation marker BSALP and the marker of osteoclast
number TRACP. The decrease in BSALP and TRACP observed in that chapter confirm
the histological data previously reported [18, 20]. The current study explored the
seasonal profiles of several circulating hormones to determine whether these hormones
change during hibernation in such a way that could prevent disuse-induced bone loss,
while decreasing bone turnover (thus preserving metabolic energy during this extended
anorectic period).

3.4.1 Maintenance of serum leptin concentrations several weeks into hibernation
may prevent bone loss and help bears maintain near-normal body
temperatures
Leptin is an energy homeostasis hormone which signals the hypothalamus to
reduce adipose tissue mass [214]. As adipose tissue accumulates it releases leptin,
which suppresses appetite, induces lipid catabolism, and produces heat [213, 214, 225,
226]. Serum leptin levels generally follow adiposity trends, such as in humans [227-229],
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mice [227], and domestic sheep [230]. In contrast, in small overwintering animals that
gain weight in the fall and fast during the winter, serum leptin becomes seasonally
dissociated from body weight and basal metabolic rate [231-233]. For instance, in
Raccoon Dogs (Nyctereutes procyonoides) [232, 234], blue foxes (Alopex lagopus)
[232], and yellow-bellied marmots (Marmota flaiventris) [233], serum leptin increases in
fall as body mass rises, but declines dramatically after the animals begin the winter fast,
preceding the gradual drop in body mass.
Although the bears in the current study experienced an average weight gain of
28% from October to January (when hibernation began), serum leptin did not
significantly increase over this period. In contrast, in small hibernators such as the
woodchuck (Marmota monax) [235], raccoon dog [232, 234], or yellow-bellied marmot
[233] serum leptin significantly increases during the months leading up to hibernation. It
is possible that the black bears in the current study began increasing serum leptin in the
months prior to the first data collection date in October, though other studies in bears do
not support this idea of earlier rises in leptin. In a study of one European brown bear
(Ursus arctos arctos), serum leptin began to rise in early October, for a total increase of
41% during prehibernation [236]. A study in Japanese black bears (Ursus thibetanus
japonicus) reported a 170% increase in serum leptin which began in October and
peaked in November (when hibernation began) [237]. The sharper increase in serum
leptin in Japanese bears was likely due to the sharper increase in weight during these
months (70%). Between the beginning of January and the end of April, the current study
observed a 37% decrease in serum leptin in black bears (Figure 3.1). Unlike in small
hibernators such as the raccoon dog [232] and the yellow-bellied marmot [233], the
decrease in serum leptin of black bears was gradual. It took place over the entire fasting
period and continued through the first month of arousal. In contrast, in a study with
yellow-bellied marmots that hibernated from October through April, serum leptin
decreased 59% between November and February, thus preceding changes in weight
(which began between January and February) [233].
There are many notable differences between a bear’s hibernation state and that
of a small hibernator. Most small hibernators can drop to ambient temperatures during
periods of torpor, and some periodically arouse to eat and excrete wastes [115, 117,
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120-122]. Most small hibernators are also believed to lose bone during hibernation [104109], though recent evidence suggests that golden-mantled ground squirrels do not
[110]. In contrast, bears only drop 1-8oC below active body temperature, do not excrete
wastes or eat, and do not lose bone during hibernation [13, 18-21, 34, 133, 161, 174]. In
small hibernators like the raccoon dog and the marmot, serum leptin decreases steeply
upon winter fast, preceding changes in weight [233, 234, 237], though in the raccoon
dog leptin levels rise again before the end of winter [234]. The decrease in serum leptin
of American black bears took place gradually through hibernation and continued into
post-hibernation (Figure 3.1). It may be an evolutionary advantage for bears to retain
raised leptin concentrations longer into hibernation, as the leptin would help them
maintain

higher

body

temperatures

and

suppress

appetite-induced

arousal.

Furthermore, serum leptin decreases by 67% in hind-limb unloaded rats, and replacing
serum leptin during unloading inhibits disuse-induced bone loss [215-217]. Therefore,
maintaining high leptin levels longer into hibernation could help bears suppress bone
loss during this extended period of disuse.

3.4.2 Reduced IGF-1 and increased NPY in the serum of hibernating bears favor
suppression of bone turnover
The current study found that serum IGF-1 decreased during hibernation in black
bears. IGF-1 also decreases in the serum of hibernating golden-mantled ground
squirrels [238], which do not lose bone during this extended period of disuse [110]. It is
possible that depressed serum levels of IGF-1 could promote the lower rate of bone
turnover observed in hibernating bears [18, 20] by slowing the rates of osteoblast [221]
and osteoclast [222-224] recruitment and activation. Such a decrease in bone turnover
may, in the unique conditions of hibernation, help preserve bone despite disuse.
Bears switch to fat metabolism during hibernation, due to anorectic conditions
[111]; therefore they may be compared to animals on high fat diets: rats fed a high
fat/low carbohydrate diet experience raised concentrations of leptin and lowered IGF-1 in
the serum [239]. These rats display depressed rates of bone formation and unchanged
bone resorption, resulting in reduced bone length and BMD of the tibia [239]. However,
these 4-week-old rats were at an age of rapid growth [239, 240] through the duration of
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the study. In contrast, studies reporting bone maintenance in hibernating bears used
adult bears, which would not have been rapidly growing [16-18, 20, 21, 174]. Due to
extended fasting periods, hibernating bears could also be compared to animals on a low
protein diet: six-month-old rats fed a low protein diet for 14 weeks exhibit reduced bone
formation and resorption [241], accompanied by reduced BMD and serum levels of
IGF-1 [242, 243]. However, these protein-restricted rats had access to carbohydrates,
unlike the hibernating bear. Both the protein-restricted and the high-fat diet animals in
these studies were able to lose calcium due to urinary excretion, whereas bears do not
excrete urine and remain eucalcemic during hibernation [35]. For bears to remain
eucalcemic while not urinating, calcium mobilized by bone resorption would be returned
to the bone by new formation. In the hibernating bear [18, 20], like diet-restricted rats
[239, 241], bone resorption and formation decrease, with an accompanying reduction in
serum IGF-1. It is possible that in the low-energy, non-growing, non-urinating state of
hibernation, IGF-1 could reduce turnover without creating an imbalance between bone
resorption and formation. This reduction in bone turnover could help conserve energy
during the extended anorectic period of hibernation.
As bears have no net production of urine during hibernation [113, 114], they can
be compared to humans with reduced renal function. In keeping with the suggestion that
reduced serum IGF-1 could slow bone turnover in the hibernating bear, serum IGF-1 is
lower in pediatric hemodialysis patients with adynamic bone disease (i.e. reduced bone
turnover) than in renal patients with normal bone formation [244]. Unfortunately, it was
not possible to verify whether there were relationships between the IGF-1 levels and
bone formation and resorption markers (BSALP and TRACP, respectively) since these
measurements were not made in the same bear serum samples. Further studies may
help clarify whether IGF-1 suppresses bone formation in hibernating bears, and whether
this reduction in formation could suppress disuse-induced bone loss in this model.
Another possible mechanism of reducing bone turnover during hibernation is by
increasing serum NPY, which suppresses osteoclast [245] and osteoblast [246]
differentiation. The current study observed inverse correlations between NPY and bone
turnover serum markers (i.e. BSALP, TRACP), suggesting that increased serum NPY
levels during hibernation could contribute to the reduced turnover in bones of hibernating
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bears. Similarly, serum NPY increases in humans as renal function decreases [247] and
is inversely correlated to BSALP (r = -0.28) and total ALP (r = -0.51) in hemodialysis
patients [248]. These data suggest a relationship between high NPY levels and low bone
turnover in human patients.
Serum serotonin decreased during hibernation in black bears. This is the first
known report of serum serotonin in a hibernator; however, serotonin levels increase in
the cerebral spinal fluid of hibernating yellow-bellied marmots [249]. Although there may
be species variations between different hibernators, it is possible that serotonin
increases in the cerebral spinal fluid and decreases in the serum during hibernation, as
serotonin cannot pass through the blood-brain barrier [250]. Serotonin promotes
proliferation of osteoblasts and differentiation of osteoclasts in vitro [219]; thus, reduced
serotonin during hibernation could favor suppressed bone turnover. However, there is
controversy about the effects of serotonin on bone in vivo (for review see: [251]), and
serotonin levels are not correlated to bone turnover markers BSALP and TRACP in
black bears. Therefore, it is difficult to draw conclusions from this data. Although there
was no seasonal variation in serum NE of black bears, it is possible that tissue sensitivity
to NE changes during hibernation. For instance, reduced temperatures can inhibit the
NE-induced lipolysis of white adipose tissue from golden-mantled ground squirrels [252].
Such an insensitivity to NE during hibernation, if exhibited in bone, could feasibly
suppress disuse-induced bone resorption since inhibiting NE with beta-blockers can
inhibit bone loss in hind-limb unloaded animals [217].
Despite these interesting findings, there were some limitations to this study. For
example, body mass was not recorded at many data collection points, so leptin could not
be directly compared to changes in body mass in these bears. Another limitation is that
serum was only collected in the months immediately surrounding and encompassing
hibernation. Thus, the bears were either preparing for hibernation, hibernating, or
recovering from hibernation throughout sample collection. It is possible that endocrine
changes between summer and hibernation would be more pronounced. Another pitfall is
that serum was collected under anesthesia, which could have an impact on endocrine
concentrations during the blood collection; however, the same dose of anesthesia was
given at each blood draw. There are possible effects of age and the birth of cubs on the
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measured serum values. However, all statistical analyses were blocked by bear to
control for inter-bear variability.

3.4.3 Summary
Bone is a complex organ which responds to many stimuli. It is likely that multiple
factors work together to maintain bone integrity during hibernation in bears. These
factors could include direct neural stimulation, as well as endocrine control. The anabolic
role of circulating PTH was previously hypothesized to help maintain hibernating bear
bone, due to its positive correlation to osteocalcin, a marker for bone formation [34]. The
current study brings to light more potential endocrine effectors of bone preservation
during hibernation. Maintaining serum leptin concentrations longer into hibernation could
help inhibit disuse-induced bone loss. Reduced IGF-1 and increased NPY in the serum
of hibernating bears could suppress bone resorption and formation rates while
sustaining balanced turnover, thus conserving energy during this extended anorectic
period. The endocrine changes observed in this study may help explain the reduced,
balanced bone turnover that occurs during the unique physiological setting in which
bears fast, reduce energy expenditure to a minimum, and remain eucalcemic despite no
urine excretion for half a year.

3.5 Tables and figures
Table 3.1—Summary of assays
The number of bears and assays that were performed in each hibernation season. The
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as
“UK.”

Season

Bears

Age (years)

Assays

2002‐2003

3 (UK)

UK

Leptin

2003‐2004

5 (5)

3‐12

Leptin, IGF‐1

2006‐2007

2 (1)

UK

Serotonin, NE

2007‐2008

4 (3)

5‐14

NPY, NE, Serotonin

2008‐2009

5 (3)

2‐21

NPY
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Data Location
Figure 3.1
Tables 3.2‐3.4
Figures 3.1, 3.5
Tables 3.2‐3.4
Figures 3.3, 3.4
Tables 3.2‐3.5
Figures 3.2‐3.4
Tables 3.2‐3.5
Tables 3.2‐3.5

Table 3.2—Serum factor longitudinal “peak-valley” analyses
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the
mean serum concentrations. Letters (A, B, C) represent values that are significantly different
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor.
“Sero.” represents serotonin.
Serum
Factor
Leptin
(ng/mL)
NPY
(pmol/L)
NE
(ng/mL)
Sero.
(ng/mL)
IGF-1
(ng/mL)

LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date
LSM+SE
Date

Fall
Active
4.08+0.39AB
11/10
193+20.2B
11/20
16.3+10.7
12/30
859+99.9
11/20
417+50.2AB
11/30

Winter
Hibernation
4.75+0.636A
1/09
246+17.8A
1/19
2.90+0.787
2/8
508+53.3
3/19
191+17.7B
2/28

Spring
Active
2.98+0.249B
4/28
175+15.1B
4/19
1.60+0.377
4/18
809+72.4
4/28
633+85.8A
4/28

Nbears

p

Power

8

0.0099

0.8334

8

0.0009

0.8907

6

0.1922

0.3081

5

0.0667

0.5281

5

0.0022

0.9803

Table 3.3—Serum factor “seasonal means” analyses
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. The p-value reported is for the partial F-test
for the serum factor.
Serum
Factor
Leptin
(ng/mL)
NPY
(pmol/L)
NE
(ng/mL)
Serotonin
(ng/mL)
IGF-1
(ng/mL)

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
(Active)
4.09+0.193A
45
194+4.42B
56
6.04+1.51
33
788+29.9A
33
387+30.7B
15

Winter
(Hibernation)
4.07+0.178A
48
219+4.19A
64
3.21+1.33
45
593+25.5B
47
203+25.4C
22

57

Spring
(Active)
3.23+0.219B
31
178+6.34B
28
3.16+2.03
19
689+40.2AB
19
597+27.5A
19

p

Power

0.0058

0.8342

<0.0001

0.9996

0.3208

0.2473

<0.0001

0.9949

<0.0001

1

Table 3.4—Serum factor linear regression models
Dependent
Variable
TRACP
BSALP
Leptin

Independent
Variable
NPY
NPY
IGF-1

Nbears

β

r

p

Power

8
8
5

-0.00328
-0.128
-0.00144

-0.528
-0.713
-0.568

<0.0001
<0.0001
0.0023

0.9986
0.9990
0.8840

Table 3.5—Serum factor effects analyses
Table reports all effects between age or cubs and serum factors, indicating the model in
which the effect was significant. For an age effect, a “+” direction indicates that the serum
factor increases with age. For a cub effect, a “+” direction indicates that the serum factor
increases if cubs were born.
Serum
Factor
Leptin
NPY
Serotonin
IGF-1
TRACP
TRACP

Effect

Model

Direction

p

Age
Age
Age
Age
Cubs
Cubs

Seasonal Means
Seasonal Means
Seasonal Means
Peak-Valley
Seasonal Means
Peak-Valley

+
+
+
+
+

0.0009
<0.0001
0.0064
0.0113
<0.0001
0.0431
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Figure 3.1—Serum leptin concentrations
Serum leptin concentrations of 8 black bears in the 2002/03 and 2003/04 seasons.
Vertical lines represent transitions between active and hibernating seasons. (A) Leptin
concentrations are represented by a line for each bear. (B) Single smoothed curve
represents the average of all 8 bears. Arrows indicate the dates at which “peak-valley”
means were analyzed. (C) Each leptin concentration was normalized to the average
leptin concentration for the appropriate bear for better comparison of seasonal fold
changes.
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Figure 3.2—Serum NPY concentrations
Serum NPY concentrations of 8 black bears in the 2007/08 and 2008/09 seasons.
Vertical lines represent transitions between active and hibernating seasons. (A) NPY
concentrations are represented by a line for each bear. (B) Single smoothed curve
represents the average of all 8 bears. Arrows indicate the dates at which “peak-valley”
means were analyzed. (C) Each NPY concentration was normalized to the average NPY
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Figure 3.3—Serum NE concentrations
Serum NE concentrations of 6 black bears in the 2006/07 and 2007/08 seasons. Vertical
lines represent transitions between active and hibernating seasons. (A) NE
concentrations are represented by a line for each bear. (B) Single smoothed curve
represents the average of all 6 bears. Arrows indicate the dates at which “peak-valley”
means were analyzed. (C) Each NE concentration was normalized to the average NE
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Figure 3.4—Serum serotonin concentrations
Serum serotonin concentrations of 6 black bears in the 2006/07 and 2007/08 seasons.
Vertical lines represent transitions between active and hibernating seasons. (A)
Serotonin concentrations are represented by a line for each bear. (B) Single smoothed
curve represents the average of all 6 bears. Arrows indicate the dates at which “peakvalley” means were analyzed. (C) Each serotonin concentration was normalized to the
average serotonin concentration for the appropriate bear for better comparison of
seasonal fold changes.
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Figure 3.5—Serum IGF-1 concentrations
Serum IGF-1 concentrations of 5 black bears in the 2003/04 season. Vertical lines
represent transitions between active and hibernating seasons. (A) IGF-1 concentrations
are represented by a line for each bear. (B) Single smoothed curve represents the
average of all 5 bears. Arrows indicate the dates at which “peak-valley” means were
analyzed. (C) Each IGF-1 concentration was normalized to the average IGF-1
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Chapter Four — Attempts to find an anti-apoptotic
environment in hibernating bear serum remain inconclusive
4.1 Introduction
Osteocyte apoptosis precedes bone loss in unloaded mice, and attenuating
osteocyte and osteoblast apoptosis with injections of PTH suppresses this bone loss
[48-51, 56]. It is possible that osteocyte and osteoblast apoptosis are required for
disuse-induced bone loss, though no known studies have directly proven this idea.
However, a study with a pan-caspase inhibitor in ovariectomized mice demonstrates that
caspase activation is required for bone loss in that model of osteoporosis [162].
Apoptosis-inducing threats (e.g. ischemia, metabolic acidosis, anorexia) are prevalent in
hibernating animals, yet qualitative observations suggest that these animals resist largescale apoptosis during hibernation (for review see: [163]). There are few in-depth studies
on the apoptotic response during hibernation, though one study demonstrates reduced
caspase-3 activation and no change in DNA laddering in the gut of hibernating ground
squirrels compared to non-hibernating squirrels [45]. Bears may attenuate bone loss
during hibernation by reducing susceptibility of osteoblasts and osteocytes to apoptosis,
possibly through the circulation of anti-apoptotic hormones. The purpose of this chapter
and the next is to determine whether serum levels of anti-apoptotic hormones increase
during hibernation, thus providing an anti-apoptotic environment for osteoblasts and
osteocytes. In this study, serum levels of the osteoblast apoptosis regulators PTH,
melatonin, and testosterone were quantified in the serum of hibernating and active
American black bears. The hypothesis was that levels of the anti-apoptotic hormones
PTH and melatonin would increase, and the levels of the pro-apoptotic hormone
testosterone would decrease in serum of hibernating bears.

4.2 Methods and materials
A total of 6 female black bears were captured and held in pens in the Virginia
Tech Center for Bear Research from fall through spring, between the years 2006 and
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2008. Samples were collected as described in section 2.2.1. Information about the bears
used for each serum assay is shown in Table 4.1. Due to limitations of serum sample
sizes, not all bears were used for all assays. The choice of bear used for each assay
depended upon sample availability at the time the assays were run. The full-length and
c-terminal PTH assays were sandwich ELISAs from Immutopics International (San
Clemente, CA). Relative optical densities were reported. Serum melatonin and
testosterone were quantified by RIA by Laurence Demmers at Pennsylvania State
University. All statistical analyses were performed using JMP 7 software. Data in tables
are presented as the LSM + SE. Graphs are represented with a point for each serum
sample, and a smoothed average curve generated with JMP software by a cubic spline.
All available samples from all bears were grouped by season (i.e. prehibernation,
hibernation, and post-hibernation) and analyzed with a single-factor ANOVA, blocking by
bear, with a Tukey’s post-hoc.

4.3 Results
Serum concentrations of hormones are reported in Table 4.2. Serum levels of
total PTH were not affected by season (Figure 4.1). However, levels of the c-terminal
fragment of PTH were significantly lower during post-hibernation compared to
prehibernation and hibernation seasons (p=0.0164), though the profiles of the two bears
were different (Figure 4.2). Testosterone decreased from 54.7 ng/dL in prehibernation to
17.4 ng/dL in post-hibernation (p=0.0361) (Figure 4.3). Melatonin was below
quantifiable levels in all serum samples.

4.4 Discussion
The goal of this study was to determine whether hormone concentrations in the
serum of hibernating bears favored anti-apoptotic conditions for osteoblasts; therefore,
concentrations of three hormones which regulate osteoblast apoptosis were quantified in
the serum of hibernating and active American black bears. Melatonin has anti-apoptotic
effects on osteoblasts [58], and administration of melatonin to ovariectomized rats
decreases apoptosis and abates bone loss [253]. However, this study found that
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concentrations of melatonin were below quantifiable levels in all samples. This finding
was independently confirmed in the serum of grizzly bears, with the anatomical
observation that the pineal gland in grizzly bears is extremely small (personal
correspondence, Heiko Jansen).
Testosterone has a decreasing trend with time in the serum of female American
black bears, such that the levels during post-hibernation are significantly lower than the
levels during prehibernation (Table 4.2). In contrast, previous findings demonstrate
increased testosterone in late hibernation in black bears [254-256]; however, these
previous studies used male bears, which probably have different circannual cycles of
androgens than females. Testosterone’s effects on bone are not fully understood. Overactivation of the androgen receptor in osteoblasts of mice increases bone turnover and
reduces bone matrix quality and whole bone strength [257]. In culture, testosterone has
pro-apoptotic effects on osteoblasts [258]. These two studies suggest that testosterone’s
direct effects on bone are catabolic. However, testosterone has anabolic effects on
tissues which positively influence bone metabolism (e.g. muscle) [259] and is a substrate
for the synthesis of estrogen, a steroid hormone with anabolic effects on bone.
Therefore, testosterone may have indirect anabolic effects on bone. Indeed,
testosterone has a positive correlation with femoral BMD and with serum levels of OCN
and BSALP in post-menopausal women [260, 261], suggesting that testosterone may
promote bone formation in vivo. The serum levels of testosterone are not significantly
different during hibernation from either active season; therefore there is no evidence that
testosterone levels promote an anti-apoptotic environment during hibernation.
PTH has anti-apoptotic effects on osteoblasts [49, 55], and intermittent injections
of PTH can inhibit bone loss [56]. The Donahue lab has previously reported an increase
in PTH from prehibernation through post-hibernation in bears [34]; however, this
previous study was incomplete and limited in size. The current study has a complete
sample set from November through April, but includes only two bears. In another study
which quantified PTH in the serum of 14 active and 27 hibernating American black
bears, no seasonal change in PTH was observed in non-lactating bears, though PTH
was lower in lactating than non-lactating bears [262]. In that study, there was only one
sampling point in each season, in contrast to the Donahue studies which had multiple
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sampling points. It is possible to miss overall seasonal trends when only viewing one
sampling point per season. A larger and more complete study must be performed before
conclusions about seasonal PTH trends can be made. Therefore, it is unclear whether
PTH increases during hibernation, thus preventing disuse-induced osteoblast and
osteocyte apoptosis. The concentrations of the c-terminal fragment of PTH were also
quantified in the serum of hibernating and active bears. C-terminal PTH promotes
osteocyte apoptosis, and inhibits bone turnover (for review see: [263]). Levels of cterminal PTH decrease significantly during the post-hibernation season (Table 4.2).
Together, the data in this study do not suggest that the serum from hibernating bears
provides an anti-apoptotic environment for osteoblasts; however, the hormones studied
here are only a few of many which can have effects on osteoblast apoptosis. Therefore,
it would be informative to determine whether the serum from hibernating bears protects
osteoblasts from apoptosis. Such a study is reported in the following chapter.

4.5 Tables and figures
Table 4.1—Summary of assays
The number of bears and assays that were performed in each hibernation season. The
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as
“UK.”

Season

Bears

Age (years)

2006‐2007

2 (1)

UK

2007‐2008

4 (3)

5‐14

Assays
PTH, c‐terminal PTH,
testosterone
melatonin

Data Location
Figures 4.1‐4.3
Table 4.2

Table 4.2—Serum factor concentrations
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. The p-value reported is for the partial F-test
for the serum factor. “Test” represents testosterone.
Serum
Factor
PTH
(relative)
C-terminal
PTH
(relative)
Test.
(ng/dL)

LSM+SE
Nsamples
LSM+SE

Fall
(Active)
12.8+3.0
12
30.7+1.9A

Winter
(Hibernation)
15.3+2.7
15
31.8+1.7A

Spring
(Active)
14.8+4.6
5
21.3+3.0B

Nsamples

12

15

5

LSM+SE
Nsamples

54.7+7.4A
45

41.2+6.6AB
48

17.4+11.5B
31
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p

Power

0.8226

0.0776

0.0164

0.7493

0.0361

0.6370
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Figure 4.1—Serum PTH concentrations
Serum PTH concentrations of 2 black bears in the 2006/07 season. Vertical lines
represent transitions between active and hibernating seasons. (A) PTH concentrations
are represented by a line for each bear. (B) Single smoothed curve represents the
average of both bears. (C) Each PTH concentration was normalized to the average PTH
concentration for the appropriate bear for better comparison of seasonal fold changes.
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Figure 4.2—Serum C-terminal PTH concentrations
Serum C-terminal PTH concentrations of 2 black bears in the 2006/07 season. Vertical
lines represent transitions between active and hibernating seasons. (A) C-terminal PTH
concentrations are represented by a line for each bear. (B) Single smoothed curve
represents the average of both bears. (C) Each C-terminal PTH concentration was
normalized to the average C-terminal PTH concentration for the appropriate bear for
better comparison of seasonal fold changes.

69

A

B

Testosterone (ng/dL)

120
100

80
60
40
20

N

D

J

F

M

A

M

0

N

D

J

F

M

A

Normalized Testosterone

C

N D J

F M A M

Figure 4.3—Serum testosterone concentrations
Serum testosterone concentrations of 2 black bears in the 2006/07 season. Vertical lines
represent transitions between active and hibernating seasons. (A) Testosterone
concentrations are represented by a line for each bear. (B) Single smoothed curve
represents the average of both bears. (C) Each testosterone concentration was
normalized to the average testosterone concentration for the appropriate bear for better
comparison of seasonal fold changes.
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Chapter Five — Serum from hibernating bears protects cells
from caspase-3 and -7 activation
5.1 Introduction
In the previous chapter, serum from hibernating and active bears was screened
for specific hormones which may suppress osteoblast and osteocyte apoptosis during
hibernation. Such a suppression of apoptosis during hibernation could prevent disuseinduced bone loss since osteocyte apoptosis precedes disuse-induced bone loss [48],
and preventing apoptosis with injections of an anti-apoptotic hormone (PTH) prevents
bone loss [49, 56]. Although none of the hormones quantified (i.e. PTH, melatonin, and
testosterone) appears to promote an anti-apoptotic environment during hibernation,
many apoptosis regulators remain unquantified. In the second stage of this aim,
MC3T3-E1 osteoblasts were cultured in serum from active and hibernating black bears.
Cell responses to apoptotic threat (i.e. serum starvation) were quantified. The hypothesis
was that osteoblasts cultured in the serum of hibernating bears would have reduced
caspase-3 activation compared to cells cultured in active bear serum. Such a reduction
in response to apoptotic threat would suggest that circulating factors in the serum of
hibernating bears provide an anti-apoptotic environment for osteoblasts, thereby
protecting the bear from bone loss.
It was reasonable to suspect that cells cultured in serum from different
physiological conditions (i.e. from hibernating and active bears) would respond
differently. Previous studies have observed changes in protein expression in cells
incubated in serum from active and hibernating animals [264, 265]. Additionally,
expression of osteoblast differentiation markers such as osteopontin, ALP activity, and
OCN have been observed in mesenchymal stem cells cultured in serum from normal or
osteoporotic patients [266] and in smooth muscle cells cultured in serum from normal or
uremic patients [267]. Thus, by culturing osteoblasts in serum from hibernating and
active bears, we could gain insight into the cellular mechanisms behind the maintenance
of bone mass during hibernation.
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5.2 Methods
5.2.1 Black bear handling and serum sample collection
A total of 11 female black bears were captured and held in pens in the Virginia
Tech Center for Bear Research from fall through spring, between the years 2006 and
2009. Samples were collected as described in section 2.2.1.

5.2.2 Cell culture
All experiments were conducted using the osteoblastic cell line MC3T3-E1,
subclone 4 (ATCC, Manassas, VA). This cell line displays markers of the osteoblast
phenotype including high ALP, type I collagen, and OCN expression when cultured in
differentiation media (α-modified Eagle’s medium (α-MEM) with 10% fetal bovine serum
(FBS), 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate) [268]. The cells were
cultured in growth media (α-MEM with 10% FBS, and 1% penicillin/streptomycin) on
100 mm culture dishes in a 5% CO2 air atmosphere at 37°C. Media was replaced every
48 hours, and cells were passaged when they reach 80% confluency. Cells were not
used beyond the tenth passage.

5.2.3 MC3T3-E1 apoptotic response to seasonal bear serum
Seasonal MC3T3-E1 response to apoptotic threat was determined by a caspase3 and -7 activity assay. Cells were seeded at 20,000 cells/well in tissue culture-treated
white-walled 96-well plates and allowed to attach overnight. Prior to starvation, cells
were primed for 24 hours in 2% FBS or bear serum. Since bear serum was collected
every 10 days, several prehibernation, hibernation, and post-hibernation serum samples
were available for each bear. Each well received a serum sample from a single bear
from one collection day. Cells were starved in serum-free α-MEM for 6 hours, unless
otherwise noted. Media was aspirated and replaced with 50 μL PBS and 50 μL
chemiluminescent DEVD substrate (Promega, Madison, WI), which releases photons
upon degradation by caspases 3 and 7. After 1 hour, luminescence was quantified by a
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Synergy HT Multi-Detection Microplate Reader (Bio-Tek, Winooski, VT). Caspase
activity was reported as relative luminescence. In studies involving inhibitors, cells were
pre-treated for one hour in 2% FBS supplemented with 1 μM SB206553, 20 μM H-89,
100 ng/mL pertussis toxin, or DMSO vehicle. Cells were then stimulated for 24 hours in
2% bear serum with inhibitors before starvation. All inhibitors were purchased from
Tocris Bioscience (Ellisville, MO). In studies involving filtered samples, molecules larger
than 10 kD were removed from α-MEM containing 2% bear serum with 10K centrifugal
filters (VWR, West Chester, PA). “Unfiltered” controls were filtered serum-free α-MEM
supplemented with 2% bear serum after filtration. Cells were cultured in filtered or
“unfiltered” samples for 24 hours prior to 6 hour starvation in serum-free media. In initial
determination of caspase-3/7 response to bear serum pre-treatment, all available
samples from October through May were used. In the studies involving inhibitors and
filtration, 3 early prehibernation (October) and 3 mid-hibernation (February) samples
were analyzed for each bear.
Seasonal cell response to apoptotic threat was also determined by Cell Death
Detection ELISA (Roche), which quantifies the amount of histone-complexed DNA
fragments in a cell lysate. Cells were seeded at 35,000 cells/cm2 in 6-well plates and
allowed to attach overnight. Cells were then stimulated with 2% bear serum for 24 hours.
After starvation for 24 hours, cells were trypsinized and 104 cells from each sample were
lysed and analyzed as described in the manufacturer’s protocol. Seasonal cell response
was also determined by with trypan blue, which stains dead cells. Cells were seeded at
35,000 cells/cm2 in 6-well plates and allowed to attach overnight. They were then
stimulated with 2% bear serum for 24 hours. After starvation for 6, 24, or 48 hours, cells
were trypsinized and counted with a hemocytometer. The ratio of live to dead cells was
determined.

5.2.4 Caspase-3/7 activity of bear bone lysates
Seven grizzly bears were housed at the Washington State University Bear
Research, Education, and Conservation Facility (Pullman, WA, USA) for this study. All
handling and treatment procedures were approved by the Washington State University
Institutional Animal Care and Use Committee. Four bears were sacrificed after 16-18
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weeks of hibernation, and 3 bears were sacrificed after at least 14 weeks of physical
activity following hibernation. Bears were euthanized by an injection of pentobarbital (10
ml per 100 lbs body weight). Transiliac crest biopsies were collected with a diamondedged 3/8” coring bit. The cortical sections were separated from the trabecular bone with
a saw. Marrow was removed from the trabecular bone with a water pick. Cortical and
trabecular sections were crushed separately into a fine powder in liquid nitrogen, and
lysed in buffer L (10mM Tris-HCl pH 8.0, 1% IGEPAL, 2mM MgCl2, 150mM NaCl). After
centrifugation to remove insoluble matter, protein concentration was quantified with the
DC Protein Assay (BioRad Laboratories, Hercules, CA). Aliquots were stored at -80oC.
15 μg of lysate was brought up to 50 μL in buffer L, and 50 μL of chemiluminescent
DEVD substrate was added. After 1 hour incubation, caspase-3/7 activity was quantified.
Caspase activity was normalized to a standard curve of purified caspase-3 (Enzo Life
Sciences, Plymouth Meeting, PA). Caspase-3/7 activity was reported in international
units (U) of activity. One U breaks down DEVD substrate at 1 pmol per minute.
5.2.5 MC3T3-E1 gene expression response to bear serum
Cells were seeded into 6-well plates at 20,000 cells/cm2 and grown overnight.
Osteoblast differentiation was cultured for 6 days in differentiation media (α-MEM with
2% bear serum, 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate), with a media
change on the third day. RNA was purified with the SV Total RNA Isolation System
(Promega, Madison, WI). Immediately after bear serum stimulation, media was
aspirated, and cells were directly lysed in 140 μL RNA lysis buffer. Quality of RNA was
assessed by gel electrophoresis and with a Nanodrop (Nanodrop Technologies,
Willmington, DE). cDNA equivalent of 300 ng RNA was generated in a 25 μL reaction
using 250U SSII reverse transcriptase, 0.5 μg oligo-dT 12-18 primer, and 25 U RNase
Out (Life Technologies, Carlsbad, CA) at 42°C for 20 minutes, 50°C for 10 minutes and
42°C for 1 hour in a gradient thermocycler (Eppendorf, Westbury, NY). Primers for all
genes of interest and the housekeeping gene were designed using PrimerQuest
software (Integrated DNA Technologies, Coralville, IA) and the NCBI gene bank
sequences, and the PCR conditions for each primer set were optimized using RNA from
MC3T3-E1 cells. SYBR Green 2X master mix (ABGene, Rochester, NY) was used to set
up PCR. cDNA equivalent of 2.5ng RNA was used in 25 μL PCR samples with 0.1 μM
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gene specific primers and 12.5 μL SYBR mix.

Forty cycles of real-time PCR was

performed using OneStep Plus (Life Technologies, Carlsbad, CA). Sample expression
was normalized to a background calibrator (samples incubated in 2% FBS), and again to
the housekeeping gene cyclophilin using a variation of the relative standard curve
method [269]. Briefly, the average threshold cycle (CT) for the 2% FBS background was
subtracted from the threshold cycle of each reaction to make ΔCT. Then the following
calculation was performed, where GOI is “gene of interest,” RG is the reference gene,
and E is the average efficiency of the primer:
∆

Eqn 5.1:

∆

Gene expression of OCN and runt-related transcription factor 2 (Runx2) were quantified.
Data was reported as relative normalized units.
5.2.6 Biochemical Assays
Serum was assayed for serotonin, adiponectin, and BSALP as described in
section 2.2.2 and for NPY as described in section 3.2.
5.2.7 Data representation and statistics
All statistical analyses were performed using JMP 7 software. Data in Tables 5.2
and 5.4 are presented as the LSM + SE. Samples were grouped by season (i.e.
prehibernation, hibernation, and post-hibernation) and analyzed with a single-factor
ANOVA, blocking by bear, with a Tukey’s post-hoc (for three seasons) or a student’s ttest (for two seasons). Correlations between serum factors and cell responses were
determined by least-squares linear regression, blocking by bear.

5.3 Results
In order to determine an appropriate time-point for quantifying caspase-3/7
activity in MC3T3-E1 cells, a time-course was performed, comparing the caspase-3/7
response to 3, 6, 9, and 18 hours of serum starvation (Figure 5.1). Caspase-3/7 activity
was highest at 6 and 9 hours of starvation, and 6 hours was chosen as the time-point for
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further assays. To determine whether bear serum had a seasonal effect in response to
apoptotic threat, MC3T3-E1 pre-osteoblasts were primed for 24 hours in seasonal bear
serum, then serum starved for 6 hours. The caspase-3/7 response to 6 hours’ serum
starvation was graphed longitudinally with a smoothed average curve (Figure 5.2). The
caspase-3/7 response began to decrease in serum collected approximately 10 days
before hibernation, and remained at a lower level throughout hibernation. In serum
collected just after hibernation, caspase-3/7 response immediately rose to levels higher
than those stimulated by prehibernation serum, suggesting a state of increased
osteoblast metabolism in post-hibernation. When samples were grouped by season and
compared by ANOVA, caspase-3/7 activity dropped from 5.66+0.23 relative units in fall
to 3.82+0.20 in winter; values then rose to 7.89+0.41 in the spring (p<0.0001) (Table
5.2). Despite this drop in caspase-3/7 activity in MC3T3-E1 osteoblasts cultured in
hibernating bear serum, no seasonal change in percent death was observed by Trypan
blue staining after 6, 24, and 48 hours of serum starvation (data not shown). Similarly,
no seasonal differences in apoptotic enrichment factor were observed with the Cell
Death Detection ELISA after 24 hours of serum starvation (data not shown). To
determine whether bone of hibernating bears confirmed the finding that caspase-3 and
-7 activity was suppressed by hibernation, bone tissue lysates were assayed.
Caspase-3/7 activity of cortical bone tissue lysates had a decreasing trend of 65% from
prehibernation to hibernation (p=0.2436) (Figure 5.3). The trabecular bone lysates had
very low levels of caspase-3/7 activity in both active and hibernating seasons (data not
shown).
Serum serotonin concentrations during the prehibernation and hibernation
seasons were correlated to the caspase-3/7 response of pre-osteoblasts cultured in
seasonal serum (r=0.807, p<0.0001), suggesting that reduced serotonin levels in the
hibernation serum might desensitize the cells to apoptotic threat. Therefore, the
5HT-2B / -2C inhibitor SB206553 was used to block the possible effects of serotonin on
the cultured osteoblasts. There was a 47% decrease in caspase-3/7 response of cells
primed in prehibernation serum compared to hibernation in the vehicle samples
(p=0.0001) and a 43% seasonal decrease in the SB206553 samples (p=0.0007) (Figure
5.4), suggesting that the 5HT-2B / -2C inhibitor did not suppress the seasonal effect of
bear serum on caspase-3/7 activity. To help narrow down the internal signaling pathway
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involved in the reduced caspase-3/7 response of cells primed in hibernation serum,
experiments were repeated with H-89 and pertussis toxin. When the protein kinase A
(PKA) pathway was inhibited with H-89, the percent decrease between cells in
prehibernation versus hibernation serum was 39% in the vehicle sample (p<0.0001) and
31% in the H-89 sample (p=0.0066) (Figure 5.5); however, H-89 reduced the
caspase-3/7 response to serum starvation by approximately 12% (p<0.0001). In a similar
experiment, the g-protein subunit Gi was blocked with pertussis toxin. In this experiment,
the toxin-treated samples had a 38% decrease in caspase-3/7 activity between cells
incubated in prehibernation or hibernation serum (p=0.0234), whereas there was a 48%
decrease between prehibernation and hibernation samples in the vehicle treatment
(p=0.0423) (Figure 5.6). Thus, neither the H-89 nor pertussis toxin had a strong impact
on the seasonal effect of bear serum on the caspase-3 and -7 response of cultured
MC3T3-E1 pre-osteoblasts.
The final attempt at characterizing the serum factor responsible for the reduced
response of pre-osteoblasts to apoptotic threat in hibernation serum was to filter out all
molecules of size greater than 10 kD. Samples were treated with filtered and unfiltered
serum for 24 hours, followed by a 6 hour serum starvation, as before. Controls using
filtered and unfiltered 2% FBS were simultaneously collected. In the unfiltered FBS
control, the starved sample had 260% higher caspase-3/7 activity than the unstarved
sample (p<0.0001); however, there was no significant difference between the starved
and unstarved samples after priming for 24 hours in filtered 2% FBS (p=0.6784) (Figure
5.7 A). These data suggest that priming for 24 hours in filtered serum prior to six hours’
serum starvation does not activate caspases 3 and 7 at this time-point. There was also
no seasonal difference between caspase activities of cells primed for 24 hours in filtered
prehibernation serum versus filtered hibernation serum (p=0.1014) (Figure 5.7 B).
Because the caspase-3/7 response to serum starvation is time-dependent and drops
back to basal levels after 24 hours of starvation (Figure 5.1), we thought that the
samples grown in filtered 2% serum may have experienced a starvation-like state during
the 24 hour priming step. Therefore, we tried a second experiment in which the cells
were cultured in filtered serum-free or 2% FBS media for 6 hours, followed by caspase
activity analysis. Under these conditions, the samples stimulated for 6 hours in filtered
serum-free media had a 27% increase in caspase-3/7 activity compared to samples
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stimulated in filtered 2% FBS (p=0.0071) (Figure 5.8 A). The cells grown for 6 hours in
filtered 2% bear serum were not significantly different between prehibernation and
hibernation seasons (p=0.4490) (Figure 5.8 B).
Serum levels of BSALP and adiponectin were positively correlated, and NPY was
inversely correlated, with the caspase-3/7 response of cultured osteoblasts to apoptotic
threat (Table 5.4). The gene expression of osteoblast differentiation markers OCN and
Runx2 increased in differentiating osteoblasts cultured in serum from post-hibernation
bears, compared to those in serum from prehibernation and hibernation bears (Table
5.2).

5.4 Discussion
Hibernating bears have a unique ability to maintain bone mechanical strength
and structural properties despite extended periods of disuse [16-21, 173, 174]. The
purpose of this study was to explore the hypothesis that a serum-borne factor in
hibernating bears suppresses osteoblast apoptosis. Such a suppression of apoptosis
may prevent disuse-induced bone loss during hibernation. MC3T3-E1 osteoblast-like
cells were cultured in serum from active and hibernating bears for 24 hours, followed by
an apoptotic threat. Figure 5.2 demonstrates a reduction in caspase-3 and -7 activation
in cells cultured in hibernating bear serum, supporting the hypothesis. These data also
demonstrate an increased caspase-3/7 response in post-hibernation serum compared to
prehibernation serum (Table 5.2), indicating the metabolic rate of bone may be
increased in the weeks immediately following hibernation. This higher metabolism in
bone was also indicated in the gene expression data (Table 5.2). Expression of OCN
and Runx2, markers of osteoblast differentiation, were significantly higher in osteoblasts
cultured in post-hibernation serum. Such an increased metabolic state in the bones of
post-hibernation bears has been indicated in previous publications [35].
The next step was to demonstrate that apoptosis decreases in the bone tissue of
hibernating bears, compared to active bears. This step has proven more difficult.
Hibernating animals are exposed to many conditions that would cause extensive tissue
damage due to apoptosis in other animals; however, they fully recover from annual
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hibernation cycles without problem [163]. Despite this ability to recover from annual
cycles of hibernation, studies have consistently shown an increase in TUNEL positive
cells in tissues from hibernating animals [45, 168, 169], which would normally indicate an
increase in apoptosis. However, one of these studies demonstrated that caspase-3
activation in the gut of hibernating ground squirrels decreases, despite increased TUNEL
positive cells [45]. Thus, TUNEL stains in hibernating tissues may be inaccurately
interpreted as an increase in apoptosis. It is possible that the increase in TUNEL positive
cells during hibernation may be due to an accumulation of damaged DNA during this
season [45]. In support of this claim, other studies have shown that TUNEL stains can
incorrectly label cells with DNA damage that are destined for repair [46]. Thus, a TUNEL
stain was not attempted on bone biopsies from bears. The caspase-3 stain for apoptotic
cells could likewise not be used on bear bone tissue, because an antibody could not be
found which would bind bear caspase-3. Therefore, this study determined the caspase
activity of bone lysate using a DEVD substrate, which is broken down by caspases 3 and
7. Only three active and four hibernating bone biopsies were available for analysis, so
this study had low power and did not attain significance. However, there was a trend for
decreased caspase-3/7 activity in the lysate of hibernating bear cortical bone compared
to lysate from active samples (Figure 5.3). These data further support the hypothesis
that apoptosis is decreased in the bones of hibernating bears, but a study with more
samples is necessary for conclusive confirmation.
The next goal of the current study was to characterize the serum factor
responsible for reduced apoptotic response of osteoblasts cultured in serum from
hibernating bears. If the post-hibernation samples were removed from analysis, serum
levels of serotonin had a strong positive correlation to the osteoblast caspase-3/7
response to apoptotic threat. Although there is no known literature of a pro-apoptotic
effect of serotonin on osteoblasts, many studies suggest that circulating serotonin has a
catabolic effect on bone (for review see: [251]). The direct effect of serotonin on MC3T3E1 proliferation is suppressed by the 5HT-2B / -2C receptor inhibitor SB206553 [219], so
this inhibitor was chosen for the current study. SB206553 did not inhibit the seasonal
effect of bear serum on MC3T3-E1 response to apoptotic threat (Figure 5.4), indicating
that if serotonin is responsible for the seasonal effect of bear serum on osteoblast
apoptotic response, then it is not through the 5HT-2B or -2C receptors; however, there
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are also 5HT-1A, -2A, and -1D receptors and 5HTT transporters on osteoblasts [270],
none of which would have been blocked by SB206553; therefore, serotonin has not
been definitely ruled out as a potential apoptosis effector in this system.
H-89 inhibits the PKA pathway, an internal signaling cascade which, in
osteoblasts, responds to a variety of hormones including parathyroid hormone, calcitonin
gene-related peptide, and norepinephrine [271-274]. H-89 can suppress anti-apoptotic
signaling in osteoblasts [272, 275, 276]; however, H-89 does not significantly suppress
the seasonal difference in apoptotic response of pre-osteoblasts primed in bear serum
(Figure 5.5), suggesting that the PKA pathway is not vital to this seasonal difference in
caspase-3/7 response. Pertussis toxin inhibits the g-protein subunit Gi. A variety of
hormones and factors can function through the Gi subunit of g-protein coupled receptors,
including parathyroid hormone, aluminum, lysophosphatidic acid, epinephrine, and
melatonin [277-280]. Pertussis toxin can suppress anti-apoptotic signaling in osteoblasts
[281, 282]. Pertussis toxin did not greatly alter the seasonal difference observed
between pre-osteoblasts primed in prehibernation and hibernation serum samples
(Figure 5.6), suggesting that the Gi subunit is not necessary for this seasonal difference
in caspase-3/7 response.
In an attempt to determine the size of the serum factor responsible for the
seasonal difference in apoptotic response, molecules larger than 10 kD were filtered out
of the media before stimulation. Samples were treated with filtered and unfiltered serum
for 24 hours, followed by a 6 hour serum starvation, as in previous experiments. There
was not a seasonal difference between cells primed in filtered prehibernation and
hibernation serum samples (Figure 5.7 B); however, there was also no difference
between starved and unstarved cells which were primed in filtered 2% FBS (Figure 5.7
A), suggesting that the 24 hour priming in filtered media suppresses caspase-3/7
response at this time-point. The caspase-3/7 response to starvation is time-dependent
(Figure 5.1), and we thought that the filtered media might induce a starvation-like state
in the cells. Therefore, we ran a second experiment in which cells were cultured in
filtered 2% FBS or serum free media for 6 hours, followed by caspase-3/7 activity
analysis. In this second experiment, there was a significant difference between the 2%
FBS and the serum-free media (Figure 5.8 A). We then cultured cells for 6 hours in
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filtered seasonal bear serum and found no significant difference between the caspase3/7 response of prehibernation and hibernation samples (Figure 5.8 B). This
suppression of the seasonal difference between cells cultured in prehibernation and
hibernation serum samples may suggest that a molecule larger than 10kD is necessary
for the seasonal difference in caspase-3/7 activity; however, the data remains
inconclusive since the experimental conditions are different than our original experiment
in which we saw the seasonal difference, and no proper control for this experiment
exists.
Least squares linear regression analysis was used to determine relationships
between the caspase-3/7 response to apoptotic threat and bone turnover markers in the
serum. Interestingly, the caspase-3/7 response was positively correlated to the serum
marker of osteoblast activity BSALP (Table 5.4), suggesting that the reduced osteoblast
response to apoptotic threat in serum from hibernating bears may be coupled to reduced
osteoblast differentiation. Previous studies have described a dependence on caspase-3
for osteoblast differentiation. For instance, MC3T3-E1 cells activate caspases 8, 2, and 3
upon stimulation of differentiation by BMP-4, and inhibitors of these caspases will
suppress the effects of BMP-4 [283]. Another study demonstrates that osteoprogenitor
cells from caspase-3-/- and caspase-3+/- mice have significantly decreased expression of
Runx2 compared to cells from wild-type mice [284]. It is possible that the higher
caspase-3/7 activity observed in osteoblasts cultured in active bear serum may be partly
due to a higher differentiation potential in these cells. If true, this would explain why we
observed a seasonal caspase-3/7 response to bear serum, but could not find any
indication that the cells were undergoing apoptosis through trypan blue exclusion and
Cell Death Detection assays.
To support the idea that the seasonal differences in caspase-3/7 response may
be due to reduced differentiation potential of cells in hibernating bear serum, regression
analysis was used to determine relationships between gene expression of osteoblast
differentiation markers and caspase-3/7 response. The seasonal caspase-3/7 response
to serum starvation after 24 hours’ pre-treatment in bear serum was positively correlated
to gene expression of OCN and Runx2 after 6 days of differentiation in seasonal bear
serum (Table 5.4). A reduction of osteoblast differentiation during hibernation may be
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favorable since differentiation would utilize metabolic energy, which bears must
conserve during hibernation. In fact, although osteoblast activity remains balanced with
osteoclast activity, activities of both cell types dramatically decrease during hibernation,
as is seen in histomorphometric data [18, 20] and serum levels of BSALP (Table 5.3).
Finally, regression analysis was used to determine what hormones may be
responsible for reduced osteoblast differentiation and caspase-3/7 activation during
hibernation. Serum levels of the neuropeptide NPY increase in the serum of hibernating
bears, and are inversely correlated with caspase-3/7 response to apoptotic threat in
osteoblasts (Table 5.4). Although there are no known studies demonstrating a
relationship between NPY and osteoblast caspase-3 and -7 response, NPY is known to
suppress osteoblast differentiation [246]. Furthermore, NPY is negatively correlated to
serum BSALP, suggesting a possible relationship between NPY and bone turnover in
the bear. Another potential effector of differentiation is adiponectin, which decreases in
the serum of hibernating bears and is positively correlated to caspase-3/7 response to
apoptotic threat in osteoblasts (Table 5.4). Again, although there are no known studies
demonstrating a relationship between adiponectin and caspase-3 and -7 response,
adiponectin has been shown to stimulate osteoblast proliferation, differentiation, and
expression of BSALP in cultured osteoblasts [202]. Adiponectin levels are positively
correlated to serum BSALP in the bears, suggesting that it, too, could be regulating
turnover during hibernation.
Bears have a unique ability to maintain bone despite prolonged mechanical
unloading (i.e. hibernation). The aim of this study was to demonstrate that a factor in the
serum of hibernating bears would protect cultured osteoblasts from apoptosis. Such a
prevention of osteoblast and osteocyte apoptosis in the bones of hibernating bears may
help maintain bone during this period of disuse. Compared to cells cultured in active
bear serum, osteoblasts cultured in serum from hibernating bears had reduced caspase3 and -7 activity and a higher percentage of living cells after 6 hours of serum starvation.
These findings suggest that the osteoblast response to apoptotic stimulus may be
reduced during hibernation. This effect did not appear to be PKA dependent or strongly
sensitive to pertussis toxin. Based upon regression analysis, two possible hormones are
NPY and adiponectin. Both hormones have an impact on osteoblast differentiation,
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which is dependent upon caspase-3 activation. It is likely that more than one serum
factor is involved in the maintenance of bone mass during hibernation in bears; however,
determining a few possible effector hormones could pinpoint new signaling pathways as
potential drug targets. This study has taken a step towards that long-term goal.

5.5 Tables and figures
Table 5.1—Summary of assays
The number of bears and assays that were performed in each hibernation season. The
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as
“UK.”

Season

Bears

Age
(years)

Assays

2006‐2007

2 (1)

UK

Caspase‐3, 6day qPCR (OCN, Runx2)

2007‐2008

4 (3)

5‐14

Caspase‐3

2‐21

SB206553 Caspase‐3, Caspase‐3,
Pertussis Toxin Caspase‐3, H‐89
Caspase‐3, 10kd and 30kd Filter
Caspase‐3

2008‐2009

5 (3)

Data Location
Figure 5.2
Tables 5.2, 5.3
Figure 5.2
Tables 5.2, 5.3
Figures 5.3‐5.7
Table 5.2, 5.3

Table 5.2—Cell responses to bear serum
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the means. Letters (A, B, C) represent values that are significantly different
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor.
Cell
Response
Caspase-3/7
OCN
Runx2

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
(Active)
5.66+0.23B
40
0.0564+0.005B
11
0.654+0.083B
11

Winter
(Hibernation)
3.82+0.20C
53
0.0549+0.004B
16
0.741+0.069B
16
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Spring
(Active)
7.89+0.41A
14
0.0983+0.007A
5
1.13+0.12A
5

p
<0.0001
<0.0001
0.0103

Table 5.3—Linear regression models
Dependent
Variable
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7

Independent
Variable
6 day OCN
6 day Runx2
BSALP
NPY
Adiponectin

Nbears

β

r

p

Power

2
2
4
4
4

0.00532
0.0535
0.130
-0.0107
0.000936

0.796
0.453
0.728
-0.437
0.493

<0.0001
0.0069
0.0066
0.0496
0.0131

0.9971
0.8058
0.8214
0.5061
0.7158
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Figure 5.1—Caspase-3/7 activity time-course
MC3T3-E1 cells were starved in serum free α-MEM for 3-24 hours. Data are represented as
LSM+SE. Units are of relative luminescence normalized to the average of the “time 0” nostarve control.
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Figure 5.2—Longitudinal analysis of caspase-3/7 response
MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, and were then starved in
serum free α-MEM for 6 hours. Caspase-3/7 response was normalized to a no-starve FBS
control. Each point represents the caspase-3/7 response from pre-incubation in one serum
sample. Vertical lines represent transitions between active and hibernating seasons. The
smoothed average curve was generated with JMP software by a cubic spline. Samples are
from 11 black bears in the 2006/07 – 08/09 seasons.
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Figure 5.3—Caspase-3/7 activity in cortical bone lysate from hibernating and active bears
Caspase-3/7 activity was quantified in 15μg protein equivalent of crushed bone lysate. Data
are represented as LSM+SEM. A t-test was used to determine the p-value, with an n=4
hibernation and 3 active samples for each season. Due to small sample size, seasonal
variation did not obtain significance (p=0.2436).
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Figure 5.4—Seasonal caspase-3/7 response with 5HT-2B / 5HT-2C inhibitor
MC3T3-E1 cells were pretreated in SB206553 for one hour, and were then cultured in
seasonal bear serum supplemented with SB206553 for 24 hours. Afterwards, they were
starved in serum free α-MEM for 6 hours. Caspase-3/7 activities were normalized to the nostarve FBS control. Caspase-3/7 activities were compared between prehibernation and
hibernation for each treatment with a student’s t-test. Both treatments had a significant
seasonal difference, indicated with asterisks (p<0.0008). Samples are from 3 black bears of
the 2008/09 season.
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Figure 5.5—Seasonal caspase-3/7 response with PKA inhibitor
MC3T3-E1 cells were pretreated in H-89 for one hour, and were then cultured in seasonal
bear serum supplemented with H-89 for 24 hours. Afterwards, they were starved in serum
free α-MEM for 6 hours. Caspase-3/7 activities were normalized to the no-starve FBS control.
Caspase-3/7 activities were compared between prehibernation and hibernation for each
treatment with a student’s t-test. Both treatments had a significant seasonal difference,
indicated with one (p<0.05) or three asterisks (p<0.0001). Samples are from 5 black bears of
the 2008/09 season.
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Figure 5.6—Seasonal caspase-3/7 response with pertussis toxin
MC3T3-E1 cells were pretreated in pertussis toxin for one hour, and were then cultured in
seasonal bear serum supplemented with pertussis toxin for 24 hours. Afterwards, they were
starved in serum free α-MEM for 6 hours. Caspase-3/7 activities were normalized to the nostarve FBS control. Caspase-3/7 activities were compared between prehibernation and
hibernation for each treatment with a student’s t-test. Both treatments had a significant
seasonal difference, indicated with an asterisk (p<0.05). Samples are from 3 black bears of
the 2008/09 season.
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Figure 5.7—Seasonal caspase-3/7 response with 24 hour prime with filtered serum
Media supplemented with 2% FBS, no serum, or 2% bear serum was filtered to remove
molecules >10kD. Cells were cultured in filtered or unfiltered media for 24 hours, followed by
a 6 hour starvation. Caspase-3/7 activities were normalized to the average of the no-starve
FBS control. (A) Comparisons between caspase activities of starved and unstarved cells after
24 hours in 2% FBS, followed by 6 hours of serum starvation. (B) Comparisons between
caspase activities of cells after 24 hours incubation in 2% prehibernation or hibernation
serum, followed by 6 hours of starvation. Bear serum samples are from 5 black bears of the
2008/09 season. Statistical significance between samples was determined with a student’s ttest and is indicated with three asterisks (p<0.0001).
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Figure 5.8—Seasonal caspase-3/7 response after 6 hour stimulation in filtered serum
Media supplemented with 2% FBS, no serum, or 2% bear serum was filtered to remove
molecules >10kD. Cells were cultured in filtered media for 6 hours. Caspase-3/7 activities
were normalized to the average of a no-starve unfiltered FBS control. (A) Comparisons
between caspase activities of cells in 2% FBS or serum free media. (B) Comparisons
between caspase activities of cells in 2% prehibernation or hibernation serum. Bear serum
samples are from 5 black bears of the 2008/09 season. Statistical significance between
samples was determined with a student’s t-test and is indicated with an asterisk (p<0.05).
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Chapter Six — MC3T3-E1 osteoblasts cultured in serum
from post-hibernation bears have higher metabolism than
osteoblasts cultured in serum from other seasons
6.1 Introduction
Hibernation is a state of energy conservation during prolonged anorectic periods.
Cell proliferation, bone formation, and bone resorption are all metabolically expensive
activities; therefore the theme of this dissertation centers on mechanisms to reduce bone
turnover during hibernation. In this study, the gene expression responses of MC3T3-E1
osteoblasts to seasonal bear serum were explored. These genes can be grouped into
four hypotheses, all suggestive of reduced proliferation and activities of bone cells during
hibernation.
The first hypothesis of this study was that cell cycle regulators favor reduced
proliferation in osteoblasts cultured in serum from hibernating bears (compared to cells
in serum from active bears). Suppressing proliferation would help preserve metabolic
energy during hibernation. Cell cycle regulation is also closely tied to apoptosis since,
upon DNA damage cells halt in the G1 or G2 phases (for review see: [285]). This halt
allows the cell time to repair itself. If repair is unsuccessful, then the apoptotic cascade is
activated. Therefore, a balance between reduced proliferation and reduced apoptosis
must be achieved during hibernation, since an increase in apoptosis could promote
irreparable tissue damage during the long months of hibernation. Qualitative
observations suggest that such tissue damage is not present in hibernating animals (for
review see: [163]). Increased TUNEL staining has been observed in various tissues of
hibernating animals [45, 168, 169], but this increase in TUNEL staining may be due to
accumulated DNA damage over the weeks of hibernation and may not lead to activation
of the caspase cascade [45]. A halt in cell cycle during hibernation may be necessary
because of accumulated DNA damage. At the same time, such a halt would prevent
excessive use of metabolic energy. The tumor-suppressor gene protein 53 (p53) is
activated upon DNA damage, resulting in a halt in the G1 phase of the cell cycle (for
review see: [41]). Thus, p53 expression was expected to increase in osteoblasts cultured
in hibernating bear serum. Cyclin D1 regulates the cell cycle by promoting progression
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beyond the G1/S checkpoint, thus inducing proliferation of osteoblast progenitors (for
review see: [286, 287]). Expression of Cyclin D1 was expected to decrease in
osteoblasts cultured in the serum from hibernating bears. Clock genes (e.g. Per1, Per2,
Bmal1) control cell cycle progression past the G1/S and G2/M checkpoints. A halt in the
G1 phase could be indirectly caused by an increase in Bmal1 through modulation of
c-myc and Cyclin D1 [285, 288, 289]. Alternatively, a halt in the G2 phase could be due
to an increase in Per1 [290]. Since a halt in either cell phase could slow proliferation and
prevent excessive use of metabolic energy, an increase in either Per1 or Bmal1 in
osteoblasts cultured in hibernating bear serum was expected.
In the second hypothesis, the caspase-3/7 response of osteoblasts cultured in
seasonal bear serum (observed in Chapter 5) was expected to be correlated to gene
expression of apoptosis regulators. In the Bcl-2 family, expression of anti-apoptotic Bcl-2
and Bcl-XL were expected to increase in osteoblasts cultured in the serum of hibernating
bears, with a concurrent decrease in expression of pro-apoptotic BAK, BAX, and BAD.
Likewise, the pro-survival gene Akt was expected to increase in osteoblast cultured in
serum from hibernating bears. Thus, osteoblasts cultured in serum from hibernating
bears were expected to favor anti-apoptotic gene expression compared to cells cultured
in serum from active bears. If such a decrease in apoptotic signaling occurred in
osteoblasts of the hibernating bear, bone resorption could be suppressed during this
period of disuse.
The third hypothesis of this study was that expression of osteoblast differentiation
markers would decrease in cells cultured in hibernating serum (compared to cells in
active serum). The transcription factor Runx2 is upregulated during the differentiation of
osteoblasts (for review see: [291]), and was expected to be lower in osteoblasts cultured
in serum from hibernating bears. Ubiquitin is a small regulatory protein which is
covalently bound to other proteins as a tag for proteolysis. It is often used as a reference
gene because its expression is ubiquitous in all cell types. In osteoblasts, Smad ubiquitin
regulatory factor 1 (Smurf1) ligates ubiquitin to Runx2 and other osteogenic regulators
(for review see: [292]). The subsequent proteolysis of these tagged proteins suppresses
osteoblast activity (i.e. matrix production, BSALP activity) [293, 294]. Smurf1 was
expected to increase in osteoblasts cultured in hibernating bear serum thus reducing
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osteoblast activity. c-fos is a proto-oncogene in the AP-1 family of transcription factors. It
is essential in the regulation of bone development (for review see: [295]) and for the
anabolic actions of PTH on bone [296, 297]. Its expression was expected to decrease in
osteoblasts cultured in hibernating bear serum. Osteopontin (OPN), collagen I (ColI),
and OCN are essential cell matrix proteins produced by osteoblasts during the formation
of bone (for review see: [298]). These genes were expected to decrease in osteoblasts
cultured in hibernating bear serum, which would suggest that a serum-borne factor is
responsible for the decreased bone formation observed in hibernating bears [18, 20].
The fourth hypothesis of this study was that expression of pro-resorptive genes
would decrease in osteoblasts cultured in serum from hibernating bears. Under catabolic
stimulation (e.g. reduced mechanical loading), osteoblasts increase expression of the
pro-resorptive cytokine receptor activator for NFκ-B ligand (RANKL) and decrease
expression of its decoy receptor OPG. An increased RANKL to OPG ratio promotes
osteoclast activation followed by the resorption of bone (for review see: [299]). Bone
resorption is decreased during hibernation in bears [18, 20]; therefore it was expected
that the expression of RANKL would decrease and OPG would increase in osteoblasts
cultured in serum from hibernating bears (compared to cells in active serum).
Macrophage colony stimulating factor (M-CSF) is a pro-resorptive cytokine expressed by
a variety of bone cells, including osteoblasts. It promotes the proliferation of osteoclast
precursors (for review see: [300]). Osteoblast expression of M-CSF was expected to
decrease in cells cultured in serum from hibernating bears.
Finally, the gene expressions of three cell-surface receptors were quantified in
osteoblasts cultured in seasonal bear serum. The PTH receptor (PTH1R) was expected
to increase in osteoblasts cultured in hibernating bear serum. This would suggest that a
factor in hibernating bear serum increases PTH signaling in osteoblasts even though the
circulating levels of PTH remain homeostatic in these serum samples (reported in
Chapter 4). An increase in PTH signaling prevents bone loss during disuse in rats [56],
and may help protect hibernating bears from bone loss. ADRβ2, the adrenergic receptor
which binds NE, was expected to decrease in osteoblasts cultured in the serum of
hibernating bears since beta-blockers inhibit bone loss due to disuse [217, 220]. As
observed in Chapter 3, although there is no seasonal variation in serum NE of black
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bears, it is possible that tissue sensitivity to NE changes during hibernation. Such an
insensitivity to NE is observed in golden-mantled ground squirrels subjected to reduced
temperature [252]. Osteoblast expression of Toll-like receptor 4 was expected to
decrease in the serum of hibernating bears (compared to serum from active bears)
because activation of TLR4 on osteoblasts induces expression of RANKL [301] and
promotes osteoblast apoptosis [302], thus promoting bone resorption.
The expressions of these genes were screened under several different cell
culture conditions in order to determine how seasonal bear serum affects osteoblast cell
response.

6.2 Methods and materials
A total of 6 female black bears were captured and held in pens in the Virginia
Tech Center for Bear Research from fall through spring, between the years 2006 and
2008. Samples were collected as described in section 2.2.1. Information about the bears
used for each serum assay is shown in Table 6.1. Due to limitations of serum sample
sizes, not all bears were used for all assays. The choice of bear used for each assay
depended upon sample availability at the time the assays were run. Cell culture was
performed as described in section 5.2.2, except that MC3T3-E1 subclone 14 osteoblasts
were used for the 3 hour differentiated condition. These cells were not used after
passage 30, since higher passage numbers have been shown to alter the phenotype of
MC3T3-E1 cells [303]. In all other cell culture studies in this report, MC3T3-E1 subclone
4 cells were used below passage 10. Subclones 4 and 14 are both mineralizing lines of
MC3T3-E1 osteoblasts and behave similarly in culture [304]. When subconfluent in
normal culture media (α-MEM, 10% FBS, 1% penicillin/streptomycin), these subclones
of MC3T3-E1 are considered pre-osteoblasts because they actively proliferate and do
not produce mineralized matrix; however, ascorbic acid stimulates the production of
extracellular matrix proteins and terminal osteoblast differentiation markers, and βglycerophosphate stimulates mineralization of the matrix.
For gene expression assays, cells were seeded at 20,000 cells/cm2 in 6-well
plates and grown overnight. Four cell culture conditions were used in this study. They
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varied the length of bear serum stimulation and the differentiation state of the MC3T3-E1
cells. After stimulation in one of four conditions, RNA was isolated, and real-time PCR
performed as described in section 5.2.5. In each condition, three potential reference
genes (β-actin, ubiquitin, cyclophilin) and the geometric means [305] of the various
combinations of reference genes were checked for seasonal trends by a single-factor
ANOVA for season, blocking by bear. The reference gene (or geometric mean) with the
lowest magnitude of seasonal variation and the highest least significant number was
chosen for normalization. Ubiquitin was later removed from reference gene analysis in
all samples since it had a significant seasonal trend in one of the conditions.
In the first condition, undifferentiated pre-osteoblasts (seeded the previous day)
were stimulated in 2% seasonal bear serum for 3 hours. Since bear serum was collected
every 10 days, several prehibernation, hibernation, and post-hibernation serum samples
were available for each bear. Each well received only one serum sample, and the bear
and date of collection were recorded. After 3 hours of stimulation, RNA was isolated.
Real-time PCR was performed on BAD, Bcl-2, Cyclin D1, Per1, PTH1R, Runx2, Smurf1,
and ubiquitin. Cyclophilin was used as a reference gene. In the second condition, after
cells were allowed to attach overnight, they were switched to differentiation media (αMEM with 10% FBS, 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate) and
grown for 6 days, with a media change on the third day. Differentiating osteoblasts were
then stimulated in differentiation media supplemented with 2% seasonal bear serum for
3 hours. Real-time PCR was performed on Akt, BAD, BAK, BAX, Bcl-XL, c-fos, MCSF,
OCN, OPG, p53, Per1, TLR4, and ubiquitin. Samples were normalized to the geometric
mean of 2 reference genes (β-actin and cyclophilin). In the third condition, after cells
were allowed to attach overnight, undifferentiated pre-osteoblasts were stimulated in
normal growth media supplemented with 2% bear serum for 24 hours. Real-time PCR
was performed on ADRβ2, Akt, BAD, BAK, BAX, Bcl-2, Bcl-XL, BmalI, ColI, Cyclin D1,
M-CSF, OCN, OPG, OPN, p53, Per1, Per2, PTH1R, RANKL, Runx2, Smurf1, TLR4, and
ubiquitin. Samples were normalized to the reference gene β-actin. In the fourth
condition, after cells were allowed to attach overnight, media was replaced with
differentiation media containing 2% bear serum (instead of FBS). Cells were allowed to
differentiate in bear serum for 6 days, with a media change on day 3. Real-time PCR
was performed on BAD, BAX, Bcl-2, c-fos, ColI, Cyclin D1, OCN, OPG, OPN, Per1,
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PTH1R, RANKL, Runx2, Smurf1, TLR4, and ubiquitin. Cyclophilin was used as the
reference gene.
All statistical analyses were performed using JMP 7 software. Data were
presented as the LSM + SE. The units were relative since all samples were normalized
to reference genes and to a reference (FBS) sample. All available samples from all
bears were grouped by season (i.e. prehibernation, hibernation, and post-hibernation)
and analyzed with a single-factor ANOVA, blocking by bear, with a Tukey’s post-hoc.
Graphs are represented with a point for each serum sample, and a smoothed average
curve generated with JMP software by a cubic spline.

6.3 Results
In the first condition (undifferentiated pre-osteoblasts stimulated for 3 hours in
seasonal bear serum), there were no seasonal trends (Table 6.2). In the second study
(differentiated osteoblasts stimulated for 3 hours in seasonal bear serum), ubiquitin
expression increased from 0.998+0.058 in osteoblasts cultured in prehibernation serum
to 1.32+0.10 in osteoblasts cultured in post-hibernation serum (p=0.0341). Expression of
ubiquitin in osteoblasts cultured in hibernation serum was not different from either active
season (Table 6.3). In the third study (undifferentiated pre-osteoblasts stimulated for 24
hours in seasonal bear serum) (Table 6.4), Akt expression increased from 0.796+0.102
in cells cultured in hibernating bear serum to 1.55+0.182 in cells cultured in posthibernation serum; there was no significant difference in Akt gene expression in cells
cultured in prehibernation bear serum compared to hibernation serum (p=0.0046).
Cyclin D1 gene expression increased from 0.950+0.032 in cells cultured in hibernation
serum to 1.12+0.05 in cells cultured in post-hibernation serum; Cyclin D1 expression
was not different in cells cultured in prehibernation serum compared to those in
hibernation nor post-hibernation serum (p=0.0177). In the fourth condition (differentiated
in bear serum for 6 days) (Table 6.5), expression of the markers for osteoblast
differentiation Runx2 and OCN were upregulated in post-hibernation compared to
prehibernation and hibernation seasons. Runx2 increased from 0.741+0.069 in cells
cultured in hibernation serum to 1.13+0.12 in cells cultured in post-hibernation serum;
Runx2 gene expression did not change in cells cultured in prehibernation serum
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compared to those in hibernation serum (p=0.0103). OCN gene expression increased
from 0.055+0.004 in osteoblasts cultured in hibernation serum to 0.098+0.01 in
osteoblasts cultured in post-hibernation serum; there was no difference in OCN
expression between cells cultured in prehibernation serum and those in hibernation
serum (p<0.0001).

6.4 Discussion
The goal of this study was to determine whether serum from hibernating bears
contained factors which suppress proliferation, apoptosis, and differentiation of cultured
osteoblasts when compared to serum from active bears. There were no gene expression
changes between osteoblasts cultured in hibernation serum compared to prehibernation
serum; however, there were several genes which were upregulated in MC3T3-E1 cells
cultured in post-hibernation serum. In differentiated osteoblasts cultured in seasonal
bear serum for three hours, the expression of ubiquitin increased throughout the timeframe of the study, with a significant increase between osteoblasts in post-hibernation
serum compared to those in prehibernation serum. This increase in ubiquitin suggests
that the metabolism of osteoblasts may be stimulated by post-hibernation serum.
Ubiquitin is a small protein which is covalently linked to proteins as a tag for proteolysis.
In osteoblasts, it is ligated to several vital regulators of differentiation including Runx2,
Smad1, and MEKK2 [292-294]. Ubiquitin also tags cell cycle (e.g. Cyclin D1) and clock
proteins (e.g. Per1, Per2, Bmal1) [306, 307] for proteolysis. The efficient recycling of
these cell cycle and clock genes is necessary for metabolically active cells. Therefore,
an increase in ubiquitin expression during post-hibernation is indicative of an increase in
the cycle of protein production and breakdown which is necessary in any active cell.
Fitting with this suggestion of high osteoblast metabolism in post-hibernation serum,
Cyclin D1 and Akt are upregulated in undifferentiated osteoblasts cultured in posthibernation serum at the 24 hour time-point. Cyclin D1 signals cells to progress past the
G1/S checkpoint (for review see: [286, 287]), and Akt promotes cell proliferation and
metabolism (for review see: [308]). Thus, increases in these genes in post-hibernation
serum suggest that serum-borne factors in post-hibernation circulation stimulate
osteoblast proliferation and activity. Finally, expression of the osteoblast differentiation
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factors Runx2 and OCN also increase in osteoblasts differentiated in post-hibernation
serum, further supporting the idea of increased osteoblast activity in this season.
In summary, the gene expression studies suggest that factors circulating in bears
in the weeks immediately following hibernation promote a hypermetabolic state in
osteoblasts. Differentiated osteoblasts have higher expression of ubiquitin and
differentiation markers, suggesting active protein metabolism and bone formation during
post-hibernation. Undifferentiated osteoblasts have higher expression of Akt and Cyclin
D1, suggesting active proliferation of osteoblasts during post-hibernation. These data fit
an earlier report of high bone turnover rate in spring-time bears [35].

6.5 Tables and figures

Table 6.1—Summary of assays
The number of bears and assays that were performed in each hibernation season. The
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as
“UK.” Assays in undifferentiated cells are labeled “UD,” and assays in differentiated cells are
labeled “D.”

Season

Bears

2006‐2007
2007‐2008

2 (1)
4 (3)

Age
(years)
UK
5‐14

Assays

Data Location

3hr UD, 3hr D, 24hr UD, 6 day D
24hr UD

Table 6.2‐6.5
Table 6.4
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Table 6.2—Gene expression 3 hour undifferentiated
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. The p-value reported is for the partial F-test for the
serum factor. Ubiquitin is abbreviated “UBQ.”
Serum
Factor
BAD
Bcl-2
Cyclin D1
Per1
PTH1R
Runx2
Smurf1
UBQ

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
(Active)
0.972+0.064
6
0.873+0.160
6
1.00+0.132
6
1.17+0.270
6
0.892+0.107
6
0.509+0.119
6
1.15+0.146
6
0.911+0.093
6

Winter
(Hibernation)
1.02+0.06
7
0.924+0.148
7
1.01+0.122
7
1.49+0.250
7
0.950+0.099
7
0.677+0.110
7
0.840+0.135
7
0.939+0.086
7
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Spring
(Active)
0.850+0.110
2
1.12+0.277
2
1.02+0.229
2
1.20+0.47
2
1.28+0.185
2
0.911+0.206
2
1.25+0.253
2
0.981+0.161
2

p

Power

0.4310

0.1704

0.7452

0.0874

0.9975

0.0503

0.6601

0.1043

0.2255

0.2867

0.2552

0.2633

0.2293

0.2836

0.9283

0.0590

Table 6.3—Gene expression 3 hour differentiated
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. Ubiquitin is abbreviated “UBQ.”
Serum
Factor
Akt
BAD
BAK
BAX
Bcl-XL
c-fos
M-CSF
OCN
OPG
p53
Per1
TLR4
UBQ

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
(Active)
0.933+0.073
12
0.744+0.103
12
0.860+0.108
12
0.860+0.108
12
1.16+0.16
12
0.963+0.135
12
1.15+0.159
12
1.11+0.19
12
1.12+0.20
12
1.27+0.24
12
3.02+0.59
12
1.28+0.35
12
0.998+0.058B
12

Winter
(Hibernation)
0.850+0.073
12
0.466+0.103
12
0.971+0.108
12
0.971+0.108
12
1.26+0.16
12
0.689+0.135
12
1.02+0.159
12
1.23+0.19
12
0.704+0.201
12
1.04+0.24
12
4.88+0.59
12
1.65+0.35
12
1.08+0.06AB
12
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Spring
(Active)
0.616+0.126
4
0.884+0.179
4
0.690+0.188
4
0.690+0.188
4
0.779+0.273
4
0.783+0.234
4
1.25+0.275
4
1.93+0.34
4
0.663+0.348
4
1.00+0.42
4
2.81+1.01
4
1.68+0.61
4
1.32+0.10A
4

p

Power

0.1169

0.4289

0.0771

0.5069

0.4261

0.1842

0.1842

0.4261

0.3329

0.2289

0.3700

0.2095

0.7252

0.0959

0.1248

0.4163

0.2867

0.2567

0.7679

0.0873

0.0658

0.5356

0.7245

0.0961

0.0341

0.6472

Table 6.4—Gene expression 24 hour undifferentiated
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. Ubiquitin is abbreviated “UBQ.”
Serum
Factor
ADRβ2
Akt
BAD
BAK
BAX
Bcl-2
Bcl-XL
BmalI
ColI
Cyclin D1
M-CSF
OCN
OPG
OPN
p53
Per1
Per2
PTH1R
RANKL
Runx2
Smurf1
TLR4
UBQ

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
(Active)
1.70+0.19
11
0.976+0.123B
11
1.46+0.22
11
1.53+0.13
11
1.50+0.09
11
1.38+0.14
11
1.32+0.10
11
1.96+0.14
11
2.80+0.28
11
1.01+0.04 AB
33
0.733+0.061
11
7.74+1.13
11
0.568+0.051
11
1.37+0.26
11
1.01+0.07
11
1.65+0.11
10
3.03+0.55
10
0.969+0.041
33
0.180+0.227
11
0.770+0.030
33
0.927+0.045
34
1.10+0.07
11
1.02+0.06
34

Winter
(Hibernation)
1.56+0.17
16
0.796+0.102B
16
1.50+0.18
16
1.30+0.10
16
1.30+0.08
16
1.13+0.12
16
1.38+0.08
16
2.11+0.11
16
2.73+0.23
16
0.950+0.032B
48
0.643+0.050
16
5.22+0.94
16
0.489+0.043
16
1.39+0.21
16
1.05+0.05
16
1.73+0.089
16
3.05+0.45
16
1.04+0.03
48
0.500+0.189
16
0.727+0.025
48
0.875+0.038
48
1.14+0.06
16
1.03+0.044
48
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Spring
(Active)
1.55+0.232
5
1.55+0.182A
5
1.23+0.32
5
1.15+0.19
5
1.28+0.14
5
0.948+0.206
5
1.16+0.15
5
1.67+0.20
5
1.92+0.41
5
1.12+0.05A
19
0.676+0.090
5
3.98+1.7
5
0.606+0.076
5
1.58+0.38
5
0.919+0.096
5
1.47+0.16
5
2.37+0.82
5
0.920+0.054
19
0.743+0.338
5
0.750+0.040
19
0.826+0.0610
19
1.28+0.10
5
1.18+0.08
19

p

Power

0.8378

0.0726

0.0046

0.8767

0.7639

0.0887

0.1959

0.3317

0.2152

0.3137

0.1832

0.3447

0.1690

0.4691

0.1830

0.3449

0.1841

0.3437

0.0177

0.7266

0.5321

0.1472

0.1285

0.4127

0.3101

0.2443

0.8944

0.0655

0.4942

0.1599

0.3730

0.2096

0.7494

0.0916

0.1110

0.4479

0.3480

0.2228

0.5560

0.1456

0.3919

0.2096

0.3507

0.2214

0.2108

0.3172

Table 6.5—Gene expression 6 day differentiated
Data are represented as LSM+SE. The total number of samples included in the ANOVA is
indicated below the mean concentrations. Letters (A, B, C) represent values that are
significantly different from each other at α=0.05. Ubiquitin is abbreviated “UBQ.”
Serum
Factor
BAD
BAX
Bcl-2
c-fos
ColI
Cyclin D1
OCN
OPG
OPN
Per1
PTH1R
RANKL
Runx2
Smurf1
TLR4
UBQ

LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples
LSM+SE
Nsamples

Fall
(Active)
1.08+0.06
11
1.39+0.15
11
0.628+0.076
11
1.07+0.09
11
1.26+0.120
11
1.30+0.083
11
0.056+0.005B
11
1.55+0.13
11
1.09+0.099
11
1.74+0.16
11
1.16+0.06
11
3.86+1.61
11
0.654+0.083B
11
1.09+0.09
11
1.15+0.07
11
0.918+0.042
11

Winter
(Hibernation)
1.01+0.05
16
1.42+0.123
16
0.605+0.063
16
1.06+0.073
16
1.05+0.10
16
1.09+0.069
16
0.055+0.004B
16
1.45+0.11
16
1.11+0.082
16
2.20+0.13
16
1.15+0.05
16
2.19+1.30
16
0.741+0.069B
16
1.03+0.08
16
1.21+0.06
16
0.794+0.035
16
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Spring
(Active)
1.09+0.084
5
1.84+0.22
5
0.812+0.113
5
1.34+0.13
5
1.39+0.18
5
1.29+0.123
5
0.098+0.01A
5
1.69+0.19
5
1.41+0.15
5
2.21+0.23
5
1.09+0.09
5
0.928+2.166
5
1.13+0.12A
5
1.40+0.14
5
1.29+0.10
5
0.905+0.062
5

p

Power

0.5550

0.1400

0.2149

0.3139

0.2821

0.2620

0.1771

0.3512

0.1824

0.3455

0.1161

0.4319

<0.0001

0.9994

0.5412

0.1443

0.1702

0.3588

0.0737

0.5161

0.8342

0.0755

0.5305

0.1462

0.0103

0.8026

0.0838

0.4927

0.5217

0.1505

0.0657

0.5365
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Figure 6.1—Longitudinal analysis of BAD gene expression in undifferentiated cells stimulated
for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.
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Figure 6.2—Longitudinal analysis of Bcl-2 gene expression in undifferentiated cells stimulated
for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.3—Longitudinal analysis of Cyclin D1 gene expression in undifferentiated cells
stimulated for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.

O

N D J F M A
Month of Serum Collection

M

Figure 6.4—Longitudinal analysis of Per1 gene expression in undifferentiated cells stimulated
for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.5—Longitudinal analysis of PTH1R gene expression in undifferentiated cells
stimulated for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.
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Figure 6.6—Longitudinal analysis of Runx2 gene expression in undifferentiated cells
stimulated for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.7—Longitudinal analysis of Smurf1 gene expression in undifferentiated cells
stimulated for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.
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Figure 6.8—Longitudinal analysis of ubiquitin gene expression in undifferentiated cells
stimulated for 3 hours in seasonal bear serum
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR
quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.

105

Akt Gene Expression

O

N D J F M A
Month of Serum Collection

M

BAD Gene Expression

Figure 6.9—Longitudinal analysis of Akt gene expression in differentiated cells stimulated for
3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.10—Longitudinal analysis of BAD gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.11—Longitudinal analysis of BAK gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.12—Longitudinal analysis of BAX gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.13—Longitudinal analysis of Bcl-XL gene expression in differentiated cells
stimulated for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.14—Longitudinal analysis of c-fos gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.15—Longitudinal analysis of M-CSF gene expression in differentiated cells
stimulated for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.16—Longitudinal analysis of OCN gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.17—Longitudinal analysis of OPG gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.18—Longitudinal analysis of p53 gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.19—Longitudinal analysis of Per1 gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.20—Longitudinal analysis of TLR4 gene expression in differentiated cells stimulated
for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.21—Longitudinal analysis of ubiquitin gene expression in differentiated cells
stimulated for 3 hours in seasonal bear serum
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by
real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.22—Longitudinal analysis of ADRβ2 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.23—Longitudinal analysis of Akt gene expression in undifferentiated cells stimulated
for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.24—Longitudinal analysis of BAD gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.

113

BAK Gene Expression

2.5
2
1.5
1
0.5
0

O

N D J F M A
Month of Serum Collection

M

BAX Gene Expression

Figure 6.25—Longitudinal analysis of BAK gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.26—Longitudinal analysis of BAX gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.27—Longitudinal analysis of Bcl-2 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.28—Longitudinal analysis of Bcl-XL gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.29—Longitudinal analysis of BmalI gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.30—Longitudinal analysis of ColI gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.31—Longitudinal analysis of Cyclin D1 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.
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Figure 6.32—Longitudinal analysis of M-CSF gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.33—Longitudinal analysis of OCN gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.34—Longitudinal analysis of OPG gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.35—Longitudinal analysis of OPN gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.36—Longitudinal analysis of p53 gene expression in undifferentiated cells stimulated
for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.37—Longitudinal analysis of Per1 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.
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Figure 6.38—Longitudinal analysis of Per2 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.39—Longitudinal analysis of PTH1R gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.
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Figure 6.40—Longitudinal analysis of RANKL gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.41—Longitudinal analysis of Runx2 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.
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Figure 6.42—Longitudinal analysis of Smurf1 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.
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Figure 6.43—Longitudinal analysis of TLR4 gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.44—Longitudinal analysis of ubiquitin gene expression in undifferentiated cells
stimulated for 24 hours in seasonal bear serum
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed
by real-time PCR quantification of relative gene expression. Each point represents the gene
expression response from one serum sample. Vertical lines represent transitions between
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.
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Figure 6.45—Longitudinal analysis of BAD gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.46—Longitudinal analysis of BAX gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.

124

Bcl‐2 Gene Expression

O

N D J F M A
Month of Serum Collection

M

Figure 6.47—Longitudinal analysis of Bcl-2 gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.48—Longitudinal analysis of c-fos gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.49—Longitudinal analysis of ColI gene expression in cells differentiated for 6 days in
seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.50—Longitudinal analysis of Cyclin D1 gene expression in cells differentiated for 6
days in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.51—Longitudinal analysis of OCN gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.

O

N D J F M A
Month of Serum Collection

M

Figure 6.52—Longitudinal analysis of OPG gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.53—Longitudinal analysis of OPN gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.54—Longitudinal analysis of Per1 gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.55—Longitudinal analysis of PTH1R gene expression in cells differentiated for 6
days in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.56—Longitudinal analysis of RANKL gene expression in cells differentiated for 6
days in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.57—Longitudinal analysis of Runx2 gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.58—Longitudinal analysis of Smurf1 gene expression in cells differentiated for 6
days in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.59—Longitudinal analysis of TLR4 gene expression in cells differentiated for 6 days
in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Figure 6.60—Longitudinal analysis of ubiquitin gene expression in cells differentiated for 6
days in seasonal bear serum
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time
PCR quantification of relative gene expression. Each point represents the gene expression
response from one serum sample. Vertical lines represent transitions between active and
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.
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Chapter Seven — Conclusion
The long-term goal of this study is to identify the biological mechanism through
which bears maintain bone despite the prolonged mechanical unloading of hibernation.
This mechanism could bring insight into new signaling pathway targets for drug
development in osteoporosis prevention. This study was broken down into three shortterm Aims. The first Aim was to determine whether serum markers of bone turnover
confirmed previously published histomorphometric data [18, 20] to suggest that
osteoclast and osteoblast activities decrease dramatically during hibernation. The bone
formation marker OCN and the resorption marker ICTP both increase during hibernation
[34], in apparent conflict with findings in histological studies. However, these turnover
markers accumulate in patients with reduced renal function, and hibernating bears can
be compared to renal patients because they do not urinate during hibernation.
Therefore, serum levels of BSALP, an indicator of osteoblast activity, and TRACP, an
indicator of osteoclast number, were quantified in active and hibernating American black
bears. Neither of these serum markers is affected by renal function. The hypothesis was
that levels of BSALP and TRACP in serum from hibernating bears would be lower
compared to levels in active bear serum.
In support of the first hypothesis, this study found that serum BSALP and TRACP
levels were significantly decreased during hibernation. These data are mentioned in
Chapters 2 and 3. In Chapter 2, positive correlations between the energy homeostasis
hormone adiponectin and serum turnover markers were discussed. Such correlations
suggest that reduced levels of adiponectin during hibernation may be partially
responsible for suppressing bone metabolism at this time of low energy expenditure.
This finding supports previous studies which demonstrate a positive relationship
between adiponectin and the activities of osteoblasts and osteoclasts [202, 203, 206].
Chapter 3 discusses an inverse correlation between serum levels of the energy
homeostasis hormone NPY and bone turnover markers. These relationships suggest
that raised levels of NPY may be partially responsible for suppressing bone metabolism
during hibernation in bears. These data support a previous study which demonstrates a
possible relationship between high serum NPY and adynamic bone disease [248], a
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condition in renal patients in which bone turnover is dramatically decreased. Other
possible effectors of low bone turnover during hibernation were discussed in Chapter 3.
These include decreased levels of IGF-1 and serotonin in the serum of bears during
hibernation. It is likely that a combination of serum factors down-regulates bone
metabolism in hibernating bears, and any of these serum factors would be interesting
subjects of further study.
The second Aim of this study was to evaluate the inter-relationship of OCN and
energy homeostasis hormones. Not only is OCN a vital component of bone’s
extracellular matrix, it can also act as an energy hormone—increasing adiponectin and
insulin secretion and promoting glucose uptake in humans and other animals. In mice,
this stimulatory effect on adiponectin and glucose is due to ucOCN [152]. The
hypothesis was that total and ucOCN would increase in the serum of hibernating bears,
with correlated increases in adiponectin and insulin and a correlated decrease in serum
glucose. In Chapter 2, increased serum levels of OCN were reported, but levels of
adiponectin and glucose were inversely correlated to total and ucOCN. Insulin levels
likewise decreased during hibernation, but with no correlation to OCN. These data
suggest that if OCN acts as an energy homeostasis hormone in bears in the months
immediately surrounding and encompassing hibernation, then it does so in a previously
unreported manner. It is possible that the unique physiological state of bears in this
season is regulated by a unique interaction of OCN with energy homeostasis. Another
surprising finding reported in Chapter 2 is that total and ucOCN were negatively
correlated to serum serotonin, and glucose and adiponectin were positively correlated to
serotonin. A correlation of serotonin to OCN has not been reported previously, and
earlier studies on the relationship between serotonin and adiponectin would suggest an
inverse relationship [189, 190]. Therefore, these relationships, too, may be due to the
unique physiological state of the weeks surrounding and encompassing hibernation.
The third Aim of this study was to evaluate serum concentrations of antiapoptotic hormones (e.g. PTH, melatonin) and to determine whether the serum from
hibernating bears had a protective effect on cultured osteoblasts submitted to an
apoptotic threat. The hypothesis was that serum levels of these anti-apoptotic hormones
would increase during hibernation in bears, and that osteoblasts cultured in serum from
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hibernating bears would have a suppressed response to apoptotic threat compared to
cells cultured in serum from active bears. Chapter 4 reported that despite previous
findings [34], serum PTH had no significant trend by season. The anti-resorptive cterminal fragment of PTH decreased during post-hibernation, which could increase bone
metabolism as previously described in post-hibernation bears [35]. Melatonin was below
quantifiable levels in all serum samples. Thus, the hormones quantified in this study did
not support the hypothesis that hibernating bear serum provides an anti-apoptotic
environment for osteoblasts, though many apoptosis regulators remain unquantified.
Despite the failure of the experiments in Chapter 4 to find anti-apoptotic
conditions in the serum of hibernating bears, Chapter 5 reports that osteoblasts cultured
in serum from hibernating bears were less responsive to apoptotic threat than cells
cultured in serum from active bears. This finding was most pronounced in the
suppressed caspase -3 and -7 response of osteoblasts grown in hibernating bear serum.
A series of experiments were performed to characterize the hormone responsible for this
reduced response. A filtration experiment suggested that the hormone of interest may be
greater than 10 kD in size, with reduced concentrations in hibernation serum. Serum
adiponectin (which is greater than 10 kD and has reduced levels during hibernation) was
positively correlated to the caspase-3/7 response. Furthermore, caspase-3/7 response
was positively correlated to gene expression of osteoblast differentiation markers OCN
and Runx2, as well as to serum levels of BSALP. These correlations suggest that the
reduction in caspase-3/7 may be partly due to the reduced differentiation potential of
osteoblasts during hibernation. Caspase-3 activation is necessary for differentiation of
osteoblasts [283, 284]. Hormonal fluctuations which could suppress osteoblast
metabolism during hibernation, such as the reduction in adiponectin levels, may do so by
suppressing caspase-3 activation. Thus, the reduced caspase-3/7 response to apoptotic
threat in osteoblasts cultured in hibernating bear serum may be an indication of reduced
osteoblast differentiation potential.
The overlying theme of this report is that bone metabolism is decreased during
hibernation, and this decrease could be modulated by an array of hormones. Such a
decrease in bone metabolism during hibernation would be beneficial, because bears
need to conserve as much energy as possible during the prolonged anorectic period of
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hibernation. This report brings to light several potential hormonal effectors of reduced
bone turnover, but raises new questions. Is it possible to attenuate disuse-induced bone
loss by inducing hypometabolic states in osteoblasts and osteoclasts? If so, such a
mechanism could be applied to protect people who are at risk of disuse induced bone
loss (e.g. paralyzed patients, astronauts, patients confined to long-term bed-rest, or
submariners). Most current studies on the effects of reduced bone turnover on bone
mechanical strength and structure suggest that this condition reduces bone strength and
BMD; however, these studies tend to take place in young (i.e. rapidly growing) rodents,
and there are no known studies on the effects of suppressing bone turnover in
conditions of disuse. The hormones brought to light in this study may work together to
desensitize bone to mechanical stimulus by inducing hypometabolic states in the
osteoblasts and osteoclasts. Studying the effects of these hormones on mechanically
unloaded bones could yield intriguing results. Therefore, this report has achieved one
small step in the long-term goal to determine the mechanism through which bears
maintain bone during hibernation and to develop a treatment for people at risk of disuse
osteoporosis.
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Appendix A—Complete tables of correlations
Table A.1—Complete list of TRACP correlations
Dep.
Variable
BSALP
Total ALP
TRACP
TRACP
PTH1R Gene
Expression
24hr UD

Indep.
Variable
TRACP
TRACP
Adiponectin
NPY

Nbears

β

r

p

Power

9
9
9
8

22.7
25.4
0.000117
-0.00328

0.723
0.726
0.430
-0.528

<0.0001
<0.0001
0.0222
<0.0001

1
1
0.6313
0.9986

TRACP

4

-0.216

-0.602

0.0267

0.6088

Table A.2—Complete list of BSAP correlations
Dep.
Variable
BSALP
Total ALP
BSALP
BSALP
BSALP
BSALP
BSALP
BSALP
Globulin
BSALP
BSALP
BSALP
Caspase-3/7

Indep.
Variable
TRACP
BSALP
Total Calcium
Adiponectin
Glucose
NPY
Albumin
Total Protein
BSALP
AST/ALT
Sodium
Chloride
BSALP

Nbears

β

r

p

Power

9
9
4
9
9
8
4
4
4
4
4
4
4

22.7
1.076
-5.79
0.00676
0.0524
-0.128
-7.82
-6.10
-0.0283
5.91
1.08
0.994
0.130

0.723
0.981
-0.687
0.627
0.602
-0.713
-0.753
-0.794
-0.748
0.712
0.695
0.703
0.728

<0.0001
<0.0001
0.0307
0.0012
0.0290
<0.0001
0.0034
0.0006
0.0209
0.0089
0.0244
0.0192
0.0066

1
1
0.6000
0.9077
0.5917
0.9990
0.8838
0.9699
0.6652
0.7855
0.6396
0.6788
0.8214
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Table A.3—Complete list of total ALP correlations
Dep.
Variable
Total ALP
Total ALP
Total ALP
Insulin
Total ALP
Total ALP
Total ALP
Total ALP
Total ALP
Total ALP
Total ALP
Total ALP
Total ALP
Total ALP
Caspase-3/7

Indep.
Variable
TRACP
BSALP
Adiponectin
Total ALP
NPY
Albumin
Total Protein
AST/ALT
BUN
Crn
BUN/Crn
Sodium
Potassium
Chloride
Total ALP

Nbears

β

r

p

Power

9
9
9
9
8
4
4
4
4
4
4
4
4
4
9

25.4
1.076
0.00840
0.0344
-0.146
-9.23
-6.54
6.10
0.356
-5.79
0.501
1.13
7.07
1.04
0.0609

0.726
0.981
0.638
0.686
-0.718
-0.744
-0.753
0.418
0.687
-0.743
0.683
0.642
0.649
0.648
0.731

<0.0001
<0.0001
0.0003
0.0112
<0.0001
0.0018
0.0013
0.0182
0.0109
0.0018
0.0065
0.0361
0.0302
0.0311
<0.0001

1
1
0.9611
0.7235
0.9995
0.9288
0.9446
0.6856
0.7611
0.9268
0.8214
0.5709
0.6025
0.5976
0.9993

Table A.4—Complete list of total calcium correlations
Dep.
Variable
BSALP
Ionized Calcium
Total Calcium
Glucose
Total Calcium
Albumin
Total Calcium
Globulin
ALT
AST/ALT
Chloride

Indep.
Variable
Total Calcium
Total Calcium
Total OCN
Total Calcium
NPY
Total Calcium
Total Protein
Total Calcium
Total Calcium
Total Calcium
Total Calcium

Nbears

β

r

p

Power

4
4
4
4
4
4
4
4
4
4
4

-5.79
0.175
-0.00522
57.8
0.00348
0.683
0.348
0.312
10.5
-0.752
-2.26

-0.687
0.542
-0.417
0.536
0.421
0.682
0.623
0.635
0.525
-0.635
-0.562

0.0307
0.0041
0.0119
0.0042
0.0154
<0.0001
<0.0001
0.0298
0.0023
<0.0001
0.0156

0.6000
0.8399
0.7269
0.8386
0.6933
0.9999
0.9985
0.5929
0.8848
0.9887
0.6915
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Table A.5—Complete list of ionized calcium correlations
Dep.
Variable
Ionized Calcium
Ionized Calcium
Ionized Calcium
Ionized Calcium
Globulin
Ionized Calcium
Ionized Calcium
Ionized Calcium
Chloride
Ionized Calcium
Ionized Calcium
ColI Gene
Expression
6day D
BAD Gene
Expression
6day D
Smurf1 Gene
Expression
6day D

Indep.
Variable
Total Calcium
Adiponectin
Glucose
Total Protein
Ionized Calcium
BUN
Crn
BUN:Crn
Ionized Calcium
Runx2 Gene
Expression 24hr UD
UBQ Gene
Expression 6day D
Ionized Calcium

Nbears

β

r

p

Power

4
4
4
4
4
4
4
4
4
6

0.175
9.05e-5
0.00106
-0.115
-1.32
0.00704
-0.102
0.0104
4.95
0.198

0.542
0.487
0.508
-0.574
-0.744
0.507
-0.520
0.517
0.553
0.989

0.0041
0.0277
0.0150
0.0012
<0.0001
0.0152
0.0095
0.0107
0.0229
0.0189

0.8399
0.6047
0.6961
0.9241
0.9960
0.6942
0.7552
0.7403
0.6352
0.6584

2

-0.237

-0.540

0.0013

0.9335

2

-2.56

-0.345

0.0362

0.5655

Ionized Calcium

2

-1.29

-0.467

0.0186

0.6748

Ionized Calcium

2

-2.08

-0.576

0.0348

0.5723
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Table A.6—Complete list of osteocalcin correlations
Dependent
Variable
Total Calcium
ucOCN
Adiponectin
Glucose
Total OCN
Serotonin
AST
ALT
AST/ALT
BUN
Crn
BUN/Crn
Total OCN
Potassium
Total OCN
Adiponectin
Glucose
Serotonin
ALT
AST/ALT
ucOCN
ucOCN
ucOCN
ucOCN
Adiponectin
Glucose
Insulin
Serotonin
AST
ALT
AST/ALT
BUN
Crn
BUN/Crn
%ucOCN

Independent
Variable
Total OCN
Total OCN
Total OCN
Total OCN
IGF-1
Total OCN
Total OCN
Total OCN
Total OCN
Total OCN
Total OCN
Total OCN
Sodium
Total OCN
Caspase-3/7
ucOCN
ucOCN
ucOCN
ucOCN
ucOCN
BUN
Crn
BUN/Crn
Caspase-3/7
%ucOCN
%ucOCN
%ucOCN
%ucOCN
%ucOCN
%ucOCN
%ucOCN
%ucOCN
%ucOCN
%ucOCN
Caspase-3/7

Nbears

β

r

p

Power

4
4
4
4
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

-0.00522
0.272
-10.43
-1.11
-0.0502
-3.87
-0.288
-0.231
0.0124
-0.167
0.0111
-0.102
2.982
-0.00392
-6.20
-26.4
-2.628
-11.2
-0.486
0.0295
-0.439
7.18
-0.523
-2.10
-23.4
-2.23
-0.0517
-8.41
-0.535
-0.439
0.0223
-0.362
0.0301
-0.222
-2.67

-0.417
0.874
-0.521
-0.627
-0.485
-0.513
-0.483
-0.699
0.475
-0.539
0.477
-0.458
0.242
-0.322
-0.426
-0.443
-0.533
-0.473
-0.525
0.581
-0.446
0.527
-0.396
-0.527
-0.484
-0.554
-0.499
-0.460
-0.175
-0.575
0.571
-0.468
0.523
-0.403
-0.491

0.0119
<0.0001
<0.0001
<0.0001
0.0265
<0.0001
0.0074
<0.0001
<0.0001
<0.0001
0.0004
0.0012
0.0371
0.0487
0.0135
0.0020
0.0048
0.0003
0.0023
0.0011
0.0021
0.0002
0.0072
0.0037
0.0004
0.0021
0.0283
0.0006
0.0500
0.0003
0.0016
0.0008
<0.0001
0.0053
0.0035

0.7269
1
0.9863
0.9883
0.6109
0.9890
0.7837
0.9999
0.9993
0.9893
0.9618
0.9218
0.5566
0.5091
0.7113
0.8873
0.8259
0.9622
0.8846
0.9625
0.8899
0.9799
0.7861
0.8502
0.9573
0.8907
0.6008
0.9462
0.5044
0.9667
0.9056
0.9420
0.9871
0.8168
0.8549
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Table A.7—Complete list of adiponectin correlations
Dep.
Variable
TRACP
BSALP
Total ALP
Ionized Calcium
Adiponectin
Adiponectin
Adiponectin
Glucose
Insulin
Adiponectin
AST
ALT
Adiponectin
Adiponectin
BUN:Crn
Potassium
Caspase-3/7

Indep.
Variable
Adiponectin
Adiponectin
Adiponectin
Adiponectin
Total OCN
ucOCN
%ucOCN
Adiponectin
Adiponectin
Serotonin
Adiponectin
Adiponectin
BUN
Crn
Adiponectin
Adiponectin
Adiponectin

Nbears

β

r

p

Power

9
9
9
4
4
4
4
4
9
4
4
4
4
4
4
4
4

0.000117
0.00676
0.00840
9.05e-5
-10.43
-26.4
-23.4
0.0291
0.00143
0.899
0.0161
0.00677
36.3
-454
0.00475
0.000232
0.000936

0.430
0.627
0.638
0.487
-0.521
-0.443
-0.484
0.427
0.709
0.411
0.527
0.500
0.551
-0.506
0.448
0.379
0.493

0.0222
0.0012
0.0003
0.0277
<0.0001
0.0020
0.0004
0.0014
<0.0001
0.0065
0.0016
0.0054
<0.0001
0.0003
0.0016
0.0148
0.0131

0.6313
0.9077
0.9611
0.6047
0.9863
0.8873
0.9573
0.9004
0.9837
0.7918
0.9056
0.8153
0.9899
0.9661
0.9063
0.6980
0.7158

Table A.8—Complete list of glucose correlations
Dep.
Variable
BSALP
Glucose
Ionized
Calcium
Glucose
Glucose
Glucose
Glucose
Glucose
Glucose
AST/ALT
Glucose
Glucose
Caspase-3/7

Indep.
Variable
Glucose
Total Calcium
Glucose

Nbears

β

r

p

Power

9
4
4

0.0524
57.8
0.00106

0.602
0.536
0.508

0.0290
0.0042
0.0150

0.5917
0.8386
0.6961

Total OCN
ucOCN
%ucOCN
Adiponectin
Serotonin
ALT
Glucose
Crn
Sodium
Glucose

4
4
4
9
4
4
4
4
4
9

-1.11
-2.628
-2.23
0.0291
0.103
2.70
-0.00580
-40.1
-8.51
0.0147

-0.627
-0.533
-0.554
0.427
0.570
0.576
-0.674
-0.558
-0.544
0.569

<0.0001
0.0048
0.0021
0.0014
0.0011
0.0009
<0.0001
0.0018
0.0032
0.0010

0.9883
0.8259
0.8907
0.9004
0.9258
0.9368
0.9982
0.9006
0.8616
0.9290
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Table A.9—Complete list of insulin correlations
Dep.
Variable
Insulin
Insulin
Insulin
Insulin
Insulin
Insulin
Insulin
Insulin
Smurf1 Gene
Expression
24hr UD

Indep.
Variable
Total ALP
%ucOCN
Adiponectin
ALT
BUN
Crn
BUN:Crn
Caspase-3/7

Nbears

β

r

p

Power

9
4
9
4
4
4
4
9

0.0344
-0.0517
0.00143
0.0643
0.106
-1.20
0.118
0.256

0.686
-0.499
0.709
0.506
0.575
-0.539
0.535
0.759

0.0112
0.0283
<0.0001
0.0429
0.0042
0.0146
0.0170
0.0422

0.7235
0.6008
0.9837
0.5324
0.8419
0.7027
0.6810
0.5329

Insulin

4

0.0362

0.606

0.0229

0.6337

Table A.10—Complete list of leptin and IGF-1 correlations
Dep.
Variable
Total OCN
Leptin

Indep.
Variable
IGF-1
IGF-1

Nbears

β

r

p

Power

5
5

-0.0502
-0.00144

-0.485
-0.568

0.0265
0.0023

0.6109
0.884

Table A.11—Complete list of NPY correlations
Dep.
Variable
TRACP
BSAP
Total ALP
Total Calcium
NPY
NPY
NPY
NPY
NPY
NPY
Caspase-3/7

Indep.
Variable
NPY
NPY
NPY
NPY
Albumin
Total Protein
ALT
AST/ALT
Sodium
Chloride
NPY

Nbears

β

r

p

Power

8
8
8
4
4
4
4
4
4
4
4

-0.00328
-0.128
-0.146
0.00348
51.7
25.6
1.24
-25.1
-6.48
-5.41
-0.0107

-0.528
-0.713
-0.718
0.421
0.649
0.582
0.508
-0.532
-0.593
-0.533
-0.437

<0.0001
<0.0001
<0.0001
0.0154
<0.0001
0.0021
0.0372
0.0153
0.0013
0.0147
0.0496

0.9986
0.9990
0.9995
0.6933
0.9881
0.8914
0.5563
0.6934
0.9190
0.6995
0.5061
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Table A.12—Complete list of norepinephrine correlations
Dep.
Variable
Norepinephrine

Indep.
Variable
Total Protein

Nbears

β

r

p

Power

4

5.78

0.378

0.0390

0.5481

Norepinephrine
PTH1R gene
expression
6 day diff
p53 gene
expression
24hr non-diff

Sodium
Norepinephrine

4
2

-1.86
0.0696

-0.452
0.535

0.0057
0.0366

0.8098
0.5649

Norepinephrine

2

-0.0910

-0.429

0.0090

0.7775

Table A.13—Complete list of serotonin correlations
Dep.
Variable
Serotonin
Serotonin
Serotonin
Adiponectin
Glucose
Serotonin
ALT
AST/ALT
Serotonin
Serotonin
BAD gene
expression
6 day diff.
Cyclin D1 gene
expression
24hr non-diff
OCN gene
expression
3hr diff

Indep.
Variable
Total OCN
ucOCN
ucOCN :Total OCN
Serotonin
Serotonin
Total Bilirubin
Serotonin
Serotonin
BUN
Creatinine
Serotonin

Nbears

β

r

p

Power

4
4
4
4
4
4
4
4
4
4
2

-3.87
-11.2
-8.41
0.899
0.103
-1673
0.0165
-0.00127
9.39
-176
0.000414

-0.513
-0.473
-0.460
0.411
0.570
-0.437
0.521
-0.657
0.364
-0.467
0.515

<0.0001
0.0003
0.0006
0.0065
0.0011
0.0161
0.0027
<0.0001
0.0270
0.0019
0.0169

0.9890
0.9622
0.9462
0.7918
0.9258
0.6870
0.8746
0.9957
0.6089
0.8975
0.6898

Serotonin

2

0.000954

0.438

0.0073

0.8004

Serotonin

2

-0.00151

0.358

0.0326

0.5860
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Table A.14—Complete list of caspase-3/7 correlations
Dep.
Variable
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7
Caspase-3/7

Indep.
Variable
Glucose
Total protein
Albumin
Globulin
BUN
Creatinine
Potassium
NPY
Insulin
ucOCN
Adiponectin
C-terminal PTH

Nbears

β

r

p

Power

9
4
4
4
4
4
4
8
9
4
9
2

0.0147
-1.02
-1.76
-1.51
0.0907
-1.55
1.41
-0.0133
0.270
-0.0853
0.00149
-0.176

0.569
-0.412
-0.415
-0.348
0.430
-0.583
0.328
-0.609
0.610
-0.483
0.660
-0.439

0.0010
0.0128
0.0120
0.0334
0.0094
0.0568
0.0431
0.0057
0.0422
0.0037
<0.0001
0.0104

0.9290
0.7268
0.7349
0.5783
0.7661
0.976
0.534
0.804
0.533
0.851
0.990
0.758
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